Adrian F. Hernandez
#92,835
Most Influential Person Now
Researcher
Adrian F. Hernandez's AcademicInfluence.com Rankings
Adrian F. Hernandezengineering Degrees
Engineering
#2244
World Rank
#3122
Historical Rank
Biomedical Engineering
#48
World Rank
#48
Historical Rank
Applied Physics
#262
World Rank
#272
Historical Rank
Electrical Engineering
#382
World Rank
#428
Historical Rank
Download Badge
Engineering
Adrian F. Hernandez's Degrees
- Masters Electrical Engineering Stanford University
- Bachelors Electrical Engineering University of California, Berkeley
Why Is Adrian F. Hernandez Influential?
(Suggest an Edit or Addition)Adrian F. Hernandez's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of Once‐Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes (2017) (1265)
- Diuretic strategies in patients with acute decompensated heart failure. (2011) (1069)
- Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. (2013) (1013)
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (2018) (993)
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (2018) (993)
- Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. (2010) (964)
- Ultrafiltration in decompensated heart failure with cardiorenal syndrome. (2012) (752)
- Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies, and Outcomes (2012) (672)
- Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry. (2018) (580)
- Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. (2013) (572)
- Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. (2017) (554)
- Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. (2020) (512)
- Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction (2008) (502)
- Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke: Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes (2011) (498)
- Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. (2014) (477)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (467)
- Systematic review of the incidence of sudden cardiac death in the United States. (2011) (465)
- Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007 (2012) (461)
- 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. (2017) (447)
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. (2016) (420)
- Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. (2013) (417)
- Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis. (2017) (415)
- Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. (2007) (393)
- Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients. (2016) (379)
- Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. (2009) (376)
- A Validated Risk Score for In-Hospital Mortality in Patients With Heart Failure From the American Heart Association Get With the Guidelines Program (2010) (366)
- Improving Door-to-Needle Times in Acute Ischemic Stroke: The Design and Rationale for the American Heart Association/American Stroke Association's Target Stroke Initiative (2011) (343)
- Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. (2009) (338)
- Incidence and prevalence of heart failure in elderly persons, 1994-2003. (2008) (333)
- Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure (2017) (328)
- Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. (2009) (313)
- Combination of loop diuretics with thiazide-type diuretics in heart failure. (2010) (311)
- Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial (2017) (293)
- Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. (2014) (285)
- Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. (2009) (279)
- Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. (2015) (272)
- Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke (2010) (268)
- Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. (2007) (267)
- Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program. (2009) (265)
- Use of aldosterone antagonists in heart failure. (2009) (263)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (250)
- Risk Score for In-Hospital Ischemic Stroke Mortality Derived and Validated Within the Get With The Guidelines–Stroke Program (2010) (249)
- Non-evidence-based ICD implantations in the United States. (2011) (247)
- Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction. (2019) (246)
- Impact of Heart Failure on Patients Undergoing Major Noncardiac Surgery (2008) (246)
- Prediction of 30-Day All-Cause Readmissions in Patients Hospitalized for Heart Failure: Comparison of Machine Learning and Other Statistical Approaches (2017) (232)
- Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. (2011) (228)
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. (2022) (225)
- Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. (2014) (222)
- Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. (2011) (210)
- Cardiohepatic interactions in heart failure: an overview and clinical implications. (2013) (207)
- Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction. (2016) (206)
- Emergency Medical Service Hospital Prenotification Is Associated With Improved Evaluation and Treatment of Acute Ischemic Stroke (2012) (203)
- Outcomes in Mild or Rapidly Improving Stroke Not Treated With Intravenous Recombinant Tissue-Type Plasminogen Activator: Findings From Get With The Guidelines–Stroke (2011) (199)
- Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. (2012) (194)
- Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen Activator (2012) (194)
- Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury (2018) (192)
- Heart failure drug treatment (2019) (190)
- Transitions of care in heart failure: a scientific statement from the American Heart Association. (2015) (187)
- Discharge to a Skilled Nursing Facility and Subsequent Clinical Outcomes Among Older Patients Hospitalized for Heart Failure (2011) (184)
- Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document (2013) (183)
- Outcomes in heart failure patients after major noncardiac surgery. (2004) (176)
- Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes: Data From Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Linked to Medicare Claims (2011) (176)
- Early and long-term outcomes of heart failure in elderly persons, 2001-2005. (2008) (173)
- Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial (2018) (167)
- Association of Intracerebral Hemorrhage Among Patients Taking Non–Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality (2018) (167)
- Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study (2015) (166)
- Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. (2012) (165)
- Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. (2011) (164)
- Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). (2009) (161)
- Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial (2017) (161)
- Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. (2012) (157)
- Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation (2017) (157)
- Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study. (2014) (157)
- Relationship of National Institutes of Health Stroke Scale to 30-Day Mortality in Medicare Beneficiaries With Acute Ischemic Stroke (2012) (155)
- Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific). (2012) (151)
- Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. (2007) (151)
- Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure (2016) (151)
- Markers of Decongestion, Dyspnea Relief, and Clinical Outcomes Among Patients Hospitalized With Acute Heart Failure (2013) (147)
- Racial and Ethnic Differences in the Treatment of Acute Myocardial Infarction: Findings From the Get With The Guidelines-Coronary Artery Disease Program (2010) (145)
- Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). (2015) (144)
- Patterns of Emergency Medical Services Use and Its Association With Timely Stroke Treatment: Findings From Get With the Guidelines-Stroke (2013) (144)
- 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2021) (141)
- Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes: Lessons Learned and Directions Forward (2010) (141)
- Data quality in the American Heart Association Get With The Guidelines-Stroke (GWTG-Stroke): results from a national data validation audit. (2012) (140)
- Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry. (2016) (139)
- Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Findings From Get With The Guidelines-Heart Failure Registry. (2015) (137)
- Times From Symptom Onset to Hospital Arrival in the Get With The Guidelines–Stroke Program 2002 to 2009: Temporal Trends and Implications (2012) (132)
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial. (2017) (132)
- Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. (2014) (130)
- Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry. (2009) (129)
- Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. (2012) (128)
- Hospital-Level Variation in Mortality and Rehospitalization for Medicare Beneficiaries With Acute Ischemic Stroke (2011) (128)
- Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial (2021) (128)
- Outcomes of Medicare Beneficiaries Undergoing Catheter Ablation for Atrial Fibrillation (2012) (128)
- Quality of care for atrial fibrillation among patients hospitalized for heart failure. (2009) (128)
- Impact of Atrial Fibrillation on Exercise Capacity in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study (2014) (127)
- Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction. (2012) (125)
- Get With The Guidelines Program Participation, Process of Care, and Outcome for Medicare Patients Hospitalized With Heart Failure (2012) (124)
- 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society (2012) (123)
- Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial. (2020) (120)
- Utility of Patient-Reported Outcome Instruments in Heart Failure. (2016) (118)
- Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries. (2010) (118)
- Trends in Use of Implantable Cardioverter-Defibrillator Therapy Among Patients Hospitalized for Heart Failure: Have the Previously Observed Sex and Racial Disparities Changed Over Time? (2012) (117)
- Incremental Value of Clinical Data Beyond Claims Data in Predicting 30-Day Outcomes After Heart Failure Hospitalization (2011) (116)
- Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review. (2019) (115)
- PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. (2012) (115)
- Do Countries or Hospitals With Longer Hospital Stays for Acute Heart Failure Have Lower Readmission Rates?: Findings From ASCEND-HF (2013) (115)
- Patient and Implanting Physician Factors Associated With Mortality and Complications After Implantable Cardioverter-Defibrillator Implantation, 2002–2005 (2008) (114)
- Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF). (2009) (112)
- Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population (2017) (111)
- Off-Hour Admission and In-Hospital Stroke Case Fatality in the Get With The Guidelines-Stroke Program (2009) (110)
- Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. (2012) (107)
- Role of Volume Redistribution in the Congestion of Heart Failure (2017) (106)
- Synthesizing Lessons Learned From Get With The Guidelines: The Value of Disease-Based Registries in Improving Quality and Outcomes (2013) (106)
- A Decade of Short-Term Outcomes in Post–Cardiac Surgery Ventricular Assist Device Implantation: Data From the Society of Thoracic Surgeons' National Cardiac Database (2007) (106)
- Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure: Insights From the Get With The Guidelines–Heart Failure Registry (2018) (106)
- Management of Postoperative Atrial Fibrillation and Subsequent Outcomes in Contemporary Patients Undergoing Cardiac Surgery: Insights From the Society of Thoracic Surgeons CAPS‐Care Atrial Fibrillation Registry (2014) (105)
- Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. (2015) (105)
- Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term OutcomesClinical Perspective (2011) (104)
- Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights from DOSE-AHF and CARRESS-HF (2015) (104)
- Representativeness of the Get With The Guidelines–Stroke Registry: Comparison of Patient and Hospital Characteristics Among Medicare Beneficiaries Hospitalized With Ischemic Stroke (2012) (103)
- National Survey of Hospital Strategies to Reduce Heart Failure Readmissions: Findings From the Get With the Guidelines-Heart Failure Registry (2012) (103)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (103)
- Troponin I in acute decompensated heart failure: insights from the ASCEND‐HF study (2011) (103)
- Presence of Atrial Fibrillation Is Independently Associated With Adverse Outcomes in Patients Hospitalized With Heart Failure: An Analysis of Get With The Guidelines–Heart Failure (2012) (103)
- Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patients. (2013) (103)
- Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry. (2016) (102)
- Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction (2017) (101)
- Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. (2012) (100)
- Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF). (2017) (99)
- Process of Care Performance Measures and Long-Term Outcomes in Patients Hospitalized With Heart Failure (2010) (99)
- End points for clinical trials in acute heart failure syndromes. (2009) (98)
- Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial (2015) (98)
- The ADAPTABLE Trial and PCORnet: Shining Light on a New Research Paradigm (2015) (97)
- Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure (2008) (96)
- Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction. (2012) (91)
- QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy. (2013) (91)
- Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines program. (2008) (90)
- Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure. (2011) (90)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (90)
- The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study. (2014) (89)
- A Risk Score for In‐Hospital Death in Patients Admitted With Ischemic or Hemorrhagic Stroke (2013) (89)
- The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification (2017) (89)
- Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure. (2016) (88)
- Recurrence of cardiac sarcoidosis in a heart transplant recipient. (2005) (88)
- Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. (2008) (87)
- Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target Stroke (2017) (87)
- SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials (2022) (86)
- Robotic partial nephrectomy versus laparoscopic cryoablation for the small renal mass. (2012) (86)
- Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial. (2016) (85)
- Representativeness of a National Heart Failure Quality-of-Care Registry: Comparison of OPTIMIZE-HF and Non–OPTIMIZE-HF Medicare Patients (2009) (85)
- Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors (2018) (85)
- Weekend hospital admission and discharge for heart failure: association with quality of care and clinical outcomes. (2009) (83)
- Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly: Findings From the Get With the Guidelines Quality-Improvement Program (2009) (83)
- Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure). (2013) (81)
- Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. (2021) (80)
- Strategies Used by Hospitals to Improve Speed of Tissue-Type Plasminogen Activator Treatment in Acute Ischemic Stroke (2014) (79)
- Left ventricular assist device destination therapy versus extended criteria cardiac transplant. (2010) (78)
- Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines -- Heart Failure Program study. (2008) (78)
- Short‐ and Long‐term Rehospitalization and Mortality for Heart Failure in 4 Racial/Ethnic Populations (2014) (78)
- Predictors of hospital length of stay in heart failure: findings from Get With the Guidelines. (2011) (78)
- Association of patient case-mix adjustment, hospital process performance rankings, and eligibility for financial incentives. (2008) (77)
- CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. (2020) (77)
- Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures (2015) (76)
- Quality of Care for Acute Coronary Syndrome Patients With Known Atherosclerotic Disease: Results From the Get With the Guidelines Program (2009) (76)
- Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program (2016) (76)
- Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure). (2011) (75)
- Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The EXACT-HF Study (2015) (75)
- N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study. (2020) (74)
- Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure. (2010) (74)
- Door-to-balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-to-balloon (D2B) Alliance. (2009) (74)
- Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic StrokeClinical Perspective (2011) (74)
- The Future of Wearables in Heart Failure Patients. (2019) (74)
- d-Dimer elevation and adverse outcomes (2014) (72)
- Heart Rate at Hospital Discharge in Patients With Heart Failure Is Associated With Mortality and Rehospitalization (2015) (72)
- Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury. (2015) (72)
- Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure (2010) (71)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. (2022) (71)
- Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE‐US registry and ADHERE‐International registry (2011) (71)
- Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes. (2016) (71)
- Diuretic response in acute heart failure-an analysis from ASCEND-HF. (2015) (70)
- Treatment and Risk in Heart Failure: Gaps in Evidence or Quality? (2010) (69)
- Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States. (2019) (68)
- Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization (2016) (67)
- Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation. (2013) (67)
- A review of dyspnea in acute heart failure syndromes. (2010) (67)
- Good Clinical Practice Guidance and Pragmatic Clinical Trials: Balancing the Best of Both Worlds. (2016) (66)
- Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure. (2008) (66)
- The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease. (2016) (66)
- Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry. (2019) (65)
- Trends in Endovascular Therapy and Clinical Outcomes Within the Nationwide Get With The Guidelines-Stroke Registry (2015) (64)
- C-index is associated with functional outcomes after laparoscopic partial nephrectomy. (2010) (64)
- Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF). (2009) (64)
- Acute decompensated heart failure: update on new and emerging evidence and directions for future research. (2013) (64)
- Utility of Socioeconomic Status in Predicting 30-Day Outcomes After Heart Failure Hospitalization (2015) (63)
- The Need for Multiple Measures of Hospital Quality: Results From the Get With The Guidelines–Heart Failure Registry of the American Heart Association (2011) (63)
- Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. (2017) (63)
- Racial and Ethnic Differences in Outcomes in Older Patients With Acute Ischemic Stroke (2013) (63)
- Device therapy in heart failure patients with chronic kidney disease. (2011) (62)
- Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. (2017) (62)
- Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study (2015) (62)
- Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction. (2014) (62)
- Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure. (2013) (61)
- Relationships between emerging measures of heart failure processes of care and clinical outcomes. (2010) (61)
- Predictors of adherence to performance measures in patients with acute myocardial infarction. (2013) (61)
- Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C (2015) (61)
- Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report. (2017) (60)
- Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG). (2010) (60)
- Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban) (2017) (60)
- Combined neprilysin and renin–angiotensin system inhibition in heart failure with reduced ejection fraction: a meta‐analysis (2016) (60)
- Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt‐pRo‐bnp in patients stabilized from an acute Heart Failure episode (PIONEER‐HF) trial (2018) (60)
- PCORnet® 2020: current state, accomplishments, and future directions (2020) (59)
- Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study. (2014) (59)
- Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study. (2019) (59)
- Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure (2018) (59)
- Outcomes of medicare beneficiaries with heart failure and atrial fibrillation. (2014) (58)
- Assessment of Home-Time After Acute Ischemic Stroke in Medicare Beneficiaries (2016) (57)
- Home-Time After Discharge Among Patients Hospitalized With Heart Failure. (2018) (57)
- Outcomes with an alternate list strategy for heart transplantation. (2005) (57)
- Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines—Heart Failure (2019) (57)
- The dissociation between door-to-balloon time improvement and improvements in other acute myocardial infarction care processes and patient outcomes. (2009) (56)
- High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. (2014) (56)
- Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee. (2012) (56)
- Characteristics, Treatments, and Outcomes of Hospitalized Heart Failure Patients Stratified by Etiologies of Cardiomyopathy. (2015) (55)
- The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND‐HF Trial (2014) (55)
- Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011. (2014) (55)
- The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease (2016) (55)
- Are we targeting the right metric for heart failure? Comparison of hospital 30-day readmission rates and total episode of care inpatient days. (2013) (55)
- Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices. (2014) (55)
- Sex and Race/Ethnicity–Related Disparities in Care and Outcomes After Hospitalization for Coronary Artery Disease Among Older Adults (2016) (55)
- DIURETIC RESPONSE IN ACUTE HEART FAILURE: AN ANALYSIS FROM ASCEND-HF (2015) (54)
- Diabetes and long-term outcomes of ischaemic stroke: findings from Get With The Guidelines-Stroke (2018) (54)
- Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack (2015) (54)
- Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. (2009) (54)
- Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure. (2015) (54)
- Valvular heart disease in patients supported with left ventricular assist devices. (2014) (54)
- Seasonal and circadian variations of acute myocardial infarction: Findings from the Get With The Guidelines–Coronary Artery Disease (GWTG‐CAD) program (2017) (54)
- In‐Hospital Worsening Heart Failure and Associations With Mortality, Readmission, and Healthcare Utilization (2014) (54)
- Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial (2019) (54)
- Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020) (53)
- Defining Heart Failure End Points in ST-Segment Elevation Myocardial Infarction Trials: Integrating Past Experiences to Chart a Path Forward (2012) (53)
- Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models. (2015) (53)
- Payment source, quality of care, and outcomes in patients hospitalized with heart failure. (2011) (52)
- Dysphagia screening and hospital-acquired pneumonia in patients with acute ischemic stroke: findings from Get with the Guidelines--Stroke. (2013) (52)
- Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care? (2011) (52)
- Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator. (2016) (52)
- Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions. (2017) (52)
- How Medicine Has Changed the End of Life for Patients With Cardiovascular Disease. (2017) (51)
- Quality of Care and Outcomes in Women Hospitalized for Heart Failure (2011) (51)
- Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. (2021) (51)
- Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes. (2009) (50)
- Targeting anti‐beta‐1‐adrenergic receptor antibodies for dilated cardiomyopathy (2013) (50)
- Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure. (2016) (50)
- Care and Outcomes of Hispanic Patients Admitted With Heart Failure With Preserved or Reduced Ejection Fraction: Findings From Get With The Guidelines–Heart Failure (2012) (50)
- The Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations. (2019) (50)
- Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM). (2013) (50)
- The safety and efficacy of full‐ versus reduced‐dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended‐Duration Betrixaban (APEX) trial (2017) (49)
- Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry. (2013) (49)
- Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals. (2010) (49)
- Increased mortality with elevated plasma endothelin‐1 in acute heart failure: an ASCEND‐HF biomarker substudy (2016) (49)
- Predictors of early dyspnoea relief in acute heart failure and the association with 30‐day outcomes: findings from ASCEND‐HF (2013) (48)
- Results of the Chronic Heart Failure Intervention to Improve MEdication Adherence (CHIME) Study: A Randomized Intervention in High-Risk Patients (2015) (48)
- An Initial Evaluation of the Impact of Pokémon GO on Physical Activity (2017) (48)
- Guideline Adherence After ST-Segment Elevation Versus Non-ST Segment Elevation Myocardial Infarction (2012) (48)
- Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction. (2013) (48)
- Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial. (2022) (47)
- Renal Dysfunction Is Associated With Poststroke Discharge Disposition and In-Hospital Mortality: Findings From Get With The Guidelines–Stroke (2017) (47)
- Comparison of Composite Measure Methodologies for Rewarding Quality of Care: An Analysis From the American Heart Association's Get With The Guidelines Program (2011) (46)
- Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) (2017) (46)
- Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data. (2016) (46)
- Renal Outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) (2018) (46)
- Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non–Vitamin K Antagonist Oral Anticoagulants Before Stroke (2017) (46)
- Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing). (2013) (46)
- Recent Nationwide Trends in Discharge Statin Treatment of Hospitalized Patients With Stroke (2010) (46)
- Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care. (2015) (46)
- Association of Get With The Guidelines-Stroke Program Participation and Clinical Outcomes for Medicare Beneficiaries With Ischemic Stroke (2016) (46)
- Splanchnic Nerve Block for Acute Heart Failure. (2018) (46)
- Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure. (2010) (45)
- Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure. (2016) (45)
- Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality. (2017) (44)
- Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial. (2019) (44)
- Racial Differences in the Prevalence and Outcomes of Atrial Fibrillation Among Patients Hospitalized With Heart Failure (2013) (44)
- Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure. (2011) (44)
- Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient‐Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study (2015) (44)
- Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND‐HF (2018) (44)
- Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial (2019) (44)
- Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial. (2020) (44)
- INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design. (2017) (43)
- Comparative effectiveness of beta-blockers in elderly patients with heart failure. (2008) (43)
- Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices (2016) (43)
- Role of guanylate cyclase modulators in decompensated heart failure (2009) (43)
- 2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement (2012) (42)
- GLP-1 Agonist Therapy for Advanced Heart Failure With Reduced Ejection Fraction: Design and Rationale for the Functional Impact of GLP-1 for Heart Failure Treatment Study (2014) (42)
- Hypotension During Hospitalization for Acute Heart Failure Is Independently Associated With 30-Day Mortality: Findings From ASCEND-HF (2014) (42)
- Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry. (2020) (42)
- Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure (2016) (42)
- Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy (2017) (42)
- Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines–Heart Failure Program (2017) (41)
- Patterns, Predictors, Variations, and Temporal Trends in Emergency Medical Service Hospital Prenotification for Acute Ischemic Stroke (2012) (41)
- Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND‐HF (2016) (41)
- Resting Ventricular–Vascular Function and Exercise Capacity in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study (2014) (41)
- Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program). (2010) (41)
- Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial). (2016) (41)
- Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction. (2021) (41)
- Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial (2018) (40)
- Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction. (2017) (40)
- Adherence to Third European Cooperative Acute Stroke Study 3- to 4.5-Hour Exclusions and Association With Outcome: Data From Get With The Guidelines-Stroke (2014) (40)
- Splanchnic nerve block for decompensated chronic heart failure: splanchnic-HF (2018) (40)
- Change the management of patients with heart failure: Rationale and design of the CHAMP‐HF registry (2017) (40)
- Relationship of Race/Ethnicity With Door‐to‐Balloon Time and Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST‐Elevation Myocardial Infarction: Findings From Get With the Guidelines–Coronary Artery Disease (2013) (40)
- Trends in Clinical, Demographic, and Biochemical Characteristics of Patients With Acute Myocardial Infarction From 2003 to 2008: A Report From the American Heart Association Get With The Guidelines Coronary Artery Disease Program (2012) (40)
- Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines–Heart Failure Registry (2018) (39)
- Randomized Trials Versus Common Sense and Clinical Observation (2020) (39)
- Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial (2018) (39)
- Peripheral Arterial Testing Before Lower Extremity Amputation Among Medicare Beneficiaries, 2000 to 2010 (2014) (39)
- Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER (2022) (39)
- Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial. (2020) (39)
- Harmony Outcomes: A randomized, double‐blind, placebo‐controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus—Rationale, design, and baseline characteristics (2018) (38)
- Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF). (2015) (38)
- Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial. (2015) (38)
- Postoperative Inotrope and Vasopressor Use Following CABG: Outcome Data from the CAPS‐Care Study (2011) (38)
- Splanchnic Nerve Block for Chronic Heart Failure. (2020) (38)
- Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. (2012) (38)
- Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial (2021) (38)
- 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2021) (38)
- Nesiritide, Renal Function, and Associated Outcomes During Hospitalization for Acute Decompensated Heart Failure: Results From the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF) (2014) (38)
- Racial/Ethnic differences in B-type natriuretic peptide levels and their association with care and outcomes among patients hospitalized with heart failure: findings from Get With The Guidelines-Heart Failure. (2013) (37)
- Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial. (2021) (37)
- High‐dose influenza vaccine to reduce clinical outcomes in high‐risk cardiovascular patients: Rationale and design of the INVESTED trial☆☆ (2018) (37)
- Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-Stroke. (2011) (37)
- Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations From the Heart Failure Society of America Guideline Committee. (2015) (37)
- Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease (2017) (37)
- Leveraging electronic health records for clinical research (2018) (37)
- Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations (2012) (37)
- Relation of dyspnea severity on admission for acute heart failure with outcomes and costs. (2015) (37)
- Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF). (2009) (35)
- Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry. (2016) (35)
- Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry. (2016) (35)
- Hospital Variation in Home-Time After Acute Ischemic Stroke: Insights From the PROSPER Study (Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research) (2016) (35)
- Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction (2020) (35)
- Regional differences in quality of care and outcomes for the treatment of acute coronary syndromes: an analysis from the get with the guidelines coronary artery disease program. (2010) (35)
- Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction (2013) (35)
- Ten-Year Experience With Extended Criteria Cardiac Transplantation (2013) (35)
- Preoperative evaluation for major noncardiac surgery: focusing on heart failure. (2004) (35)
- Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial. (2020) (34)
- Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure (2018) (34)
- Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure: The Need for Further Evidence Generation and Practice Guidelines Optimization. (2020) (34)
- Insurance status and outcome after intracerebral hemorrhage: findings from Get With The Guidelines-stroke. (2014) (34)
- Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial (2019) (34)
- Racial/Ethnic Differences in Process of Care and Outcomes Among Patients Hospitalized With Intracerebral Hemorrhage (2014) (34)
- PCSK9 Inhibitor Use in the Real World: Data From the National Patient‐Centered Research Network (2019) (34)
- Generating comparative evidence on new drugs and devices after approval (2020) (34)
- Time for NIH to lead on data sharing (2020) (33)
- Reperfusion Strategies and Quality of Care in 5339 Patients Age 80 Years or Older Presenting With ST‐Elevation Myocardial Infarction: Analysis from Get With The Guidelines‐Coronary Artery Disease (2012) (33)
- Sustained sex‐based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry (2018) (33)
- Contemporary performance of surgical ventricular restoration procedures: data from the Society of Thoracic Surgeons' National Cardiac Database. (2006) (33)
- The importance of consistent, high-quality acute myocardial infarction and heart failure care results from the American Heart Association's Get with the Guidelines Program. (2011) (33)
- Chronic Kidney Disease and Bleeding Complications After Intravenous Thrombolytic Therapy for Acute Ischemic Stroke (2014) (33)
- Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations: JACC State-of-the-Art Review. (2020) (33)
- Transient and persistent worsening renal function during hospitalization for acute heart failure. (2014) (33)
- The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND‐HF (2016) (33)
- Representativeness of RELAX-AHF Clinical Trial Population in Acute Heart Failure (2014) (33)
- Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACS. (2016) (33)
- Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States (2018) (33)
- Predicting costs among medicare beneficiaries with heart failure. (2012) (32)
- Temporal Trends and Variation in Early Scheduled Follow-Up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure (2016) (32)
- Impact of the Early Phase of the COVID-19 Pandemic on US Healthcare Workers: Results from the HERO Registry (2021) (32)
- Nitrate’s Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction Trial: Rationale and Design (2015) (32)
- Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. (2018) (32)
- Minding the gap between efforts to reduce readmissions and disparities. (2011) (32)
- International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation. (2011) (31)
- Assessing Frailty in Patients Undergoing Destination Therapy Left Ventricular Assist Device: Observations from Interagency Registry for Mechanically Assisted Circulatory Support (2017) (31)
- Depressive Symptoms and Risk of Cardiovascular Events in Blacks: Findings From the Jackson Heart Study (2015) (31)
- Smoking Paradox in Patients Hospitalized With Coronary Artery Disease or Acute Ischemic Stroke: Findings From Get With The Guidelines (2015) (31)
- Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%. (2014) (31)
- Variation in perioperative vasoactive therapy in cardiovascular surgical care: data from the Society of Thoracic Surgeons. (2009) (31)
- Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial (2017) (31)
- Guideline-Directed Low-Density Lipoprotein Management in High-Risk Patients With Ischemic Stroke: Findings From Get With The Guidelines-Stroke 2003 to 2012 (2014) (30)
- Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL (2019) (30)
- Patterns of Care Quality and Prognosis Among Hospitalized Ischemic Stroke Patients With Chronic Kidney Disease (2014) (30)
- Association of Arterial Pulse Pressure With Long-Term Clinical Outcomes in Patients With Heart Failure. (2016) (30)
- Hospital Variation in Intravenous Inotrope Use for Patients Hospitalized With Heart Failure: Insights From Get With The Guidelines (2014) (30)
- Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease. (2015) (30)
- Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women (2016) (30)
- High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction. (2019) (29)
- Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines–Heart Failure Registry (2018) (29)
- Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From ASCEND-HF. (2016) (29)
- Associations between use of the hospitalist model and quality of care and outcomes of older patients hospitalized for heart failure. (2013) (29)
- Cardiac transplantation for older patients: Characteristics and outcomes in the septuagenarian population. (2015) (29)
- Current quality of cardiovascular prevention for Million Hearts: an analysis of 147,038 outpatients from The Guideline Advantage. (2014) (29)
- Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy. (2018) (28)
- Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure. (2016) (28)
- Achievement of Guideline-Concordant Care and In-Hospital Outcomes in Patients With Coronary Artery Disease in Teaching and Nonteaching Hospitals: Results From the Get With The Guidelines–Coronary Artery Disease Program (2013) (28)
- Primary prevention implantable cardioverter-defibrillators and survival in older women. (2015) (28)
- Care and Outcomes of Asian-American Acute Myocardial Infarction Patients: Findings From the American Heart Association Get With The Guidelines-Coronary Artery Disease Program (2012) (28)
- Targeting the Kidney in Acute Heart Failure: Can Old Drugs Provide New Benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial (2013) (28)
- Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients: Design and Rationale of the EXACT-HF Study (2013) (28)
- Acute Heart Failure: Alternatives to Hospitalization. (2017) (28)
- Association between potassium level and outcomes in heart failure with reduced ejection fraction: a cohort study from the Swedish Heart Failure Registry (2020) (28)
- Impact of left ventricular assist device bridging on posttransplant outcomes. (2009) (27)
- Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study. (2018) (27)
- Influence of hospital length of stay for heart failure on quality of care. (2008) (27)
- Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL (2018) (27)
- Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials. (2018) (27)
- Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the Project of Ex-vivo Vein Graft Engineering via Transfection IV trial. (2015) (27)
- 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary (2022) (27)
- Predictors of Incident Heart Failure Hospitalizations Among Patients With Impaired Glucose Tolerance: Insight From the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Study (2013) (27)
- Patient and hospital characteristics associated with traditional measures of inpatient quality of care for patients with heart failure. (2012) (27)
- Clinical Effectiveness of Hydralazine–Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry (2016) (27)
- Use of Guideline‐Recommended Therapies for Heart Failure in the Medicare Population (2010) (26)
- Intravenous Tissue Plasminogen Activator in Stroke Mimics. (2019) (26)
- Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease. (2015) (26)
- Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF. (2019) (26)
- Global Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial: Findings From the Acute Study Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF) (2013) (26)
- Diabetes, quality of care, and in-hospital outcomes in patients hospitalized with heart failure. (2011) (26)
- Leveraging Behavioral Economics to Improve Heart Failure Care and Outcomes (2017) (26)
- Association of the Affordable Care Act’s Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure (2018) (26)
- Characteristics and Treatments of Patients Enrolled in the CHAMP‐HF Registry Compared With Patients Enrolled in the PARADIGM‐HF Trial (2018) (26)
- Utilization of hospice and predicted mortality risk among older patients hospitalized with heart failure: findings from GWTG-HF. (2012) (25)
- Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease. (2019) (25)
- Assessing the Quality and Comparative Effectiveness of Team-Based Care for Heart Failure: Who, What, Where, When, and How. (2015) (25)
- Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial (2017) (25)
- Rationale and Design of the VITALITY-HFpEF Trial. (2019) (25)
- Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure). (2017) (25)
- Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients. (2020) (25)
- Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial). (2016) (25)
- Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes (2017) (24)
- Pharmacotherapy in Medicare beneficiaries with atrial fibrillation. (2012) (24)
- Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States. (2013) (24)
- The Burden of Congestion in Patients Hospitalized With Acute Decompensated Heart Failure. (2019) (24)
- Hospitalized hemorrhagic stroke patients with renal insufficiency: clinical characteristics, care patterns, and outcomes. (2014) (24)
- Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1‐receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction (2018) (24)
- Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction (2021) (23)
- High‐Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network (2018) (23)
- Quality of acute myocardial infarction care and outcomes in 33,997 patients aged 80 years or older: findings from Get With The Guidelines-Coronary Artery Disease (GWTG-CAD). (2011) (23)
- Acute Heart Failure: Perspectives From a Randomized Trial and a Simultaneous Registry (2012) (23)
- Do heart failure disease management programs make financial sense under a bundled payment system? (2010) (23)
- Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial (2015) (23)
- Insufficient reduction in heart rate during hospitalization despite beta‐blocker treatment in acute decompensated heart failure: insights from the ASCEND‐HF trial (2017) (23)
- Comparative Effectiveness of Cardiac Resynchronization Therapy With an Implantable Cardioverter-Defibrillator Versus Defibrillator Therapy Alone (2014) (23)
- Resting Heart Rate and Long-term Outcomes Among the African American Population: Insights From the Jackson Heart Study (2017) (23)
- Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and Costs. (2016) (23)
- Abstract WP313: Quality of Ischemic Stroke-related Care in Patients With Chronic Kidney Disease (CKD) on Dialysis: Findings From Get With the Guidelines-stroke (2016) (23)
- Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States. (2016) (22)
- Advanced heart failure. (2011) (22)
- Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND‐HF (2018) (22)
- Circulating Neprilysin in Patients with Heart Failure with Preserved Ejection Fraction. (2020) (22)
- Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF. (2019) (21)
- Symptomatic event reduction with extended‐duration betrixaban in acute medically ill hospitalized patients (2017) (21)
- Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations (2021) (21)
- Machine learning to predict venous thrombosis in acutely ill medical patients (2020) (21)
- Use and predictors of heart failure disease management referral in patients hospitalized with heart failure: insights from the Get With the Guidelines Program. (2011) (21)
- Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF. (2019) (21)
- Medicare Expenditures by Race/Ethnicity After Hospitalization for Heart Failure With Preserved Ejection Fraction. (2018) (21)
- Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies. (2010) (21)
- Association of insurance status with inpatient treatment for coronary artery disease: findings from the Get With the Guidelines program. (2010) (21)
- Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non–Vitamin K Antagonist Oral Anticoagulants Preceding Stroke (2018) (21)
- Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: Results From the EXSCEL Trial. (2019) (21)
- Left ventricular assessment in myocardial infarction: the VALIANT registry. (2005) (21)
- Implantable left ventricular assist devices: new hope for patients with end-stage heart failure. (2006) (21)
- Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial). (2018) (21)
- Ventricular Conduction and Long-Term Heart Failure Outcomes and Mortality in African Americans: Insights From the Jackson Heart Study (2015) (20)
- Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the VICTORIA trial (2021) (20)
- Diastolic Dysfunction in Patients with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results from the CHART Study. (2020) (20)
- Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation. (2014) (20)
- Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND‐HF (2018) (20)
- Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing?: an analysis of 107,096 patients from the National Cardiovascular Data Registry's ICD Registry. (2012) (20)
- Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease (2016) (20)
- Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the Apex Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial) (2018) (20)
- Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). (2015) (19)
- Lack of impact of electronic health records on quality of care and outcomes for ischemic stroke. (2015) (19)
- Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND‐HF (2015) (19)
- Safety and efficacy of the partial adenosine A1 receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced ejection fraction: a phase IIb, randomized, double‐blind, placebo‐controlled trial (2019) (19)
- Splanchnic Nerve Block Mediated Changes in Stressed Blood Volume in Heart Failure. (2021) (19)
- Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation. (2020) (19)
- Temporal trends in clinical characteristics of patients without known cardiovascular disease with a first episode of myocardial infarction. (2014) (19)
- Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association's Get with the Guidelines--Coronary Artery Disease database). (2008) (19)
- Quality of Care and Outcomes Among Patients With Acute Myocardial Infarction by Level of Kidney Function at Admission: Report From the Get With The Guidelines Coronary Artery Disease Program (2012) (19)
- Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial. (2019) (19)
- Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial (2017) (19)
- The burden of non‐cardiac comorbidities and association with clinical outcomes in an acute heart failure trial – insights from ASCEND‐HF (2020) (19)
- Sex Differences in the Management and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients Presenting to the Emergency Department With Acute Heart Failure. (2015) (19)
- Comparison of Performance Achievement Award Recognition With Primary Stroke Center Certification for Acute Ischemic Stroke Care (2013) (19)
- Guideline-Appropriate Care and In-Hospital Outcomes in Patients With Heart Failure in Teaching and Nonteaching Hospitals: Findings From Get With The Guidelines–Heart Failure (2016) (18)
- The future of cardiovascular clinical research in North America and beyond-addressing challenges and leveraging opportunities through unique academic and grassroots collaborations. (2015) (18)
- Does Age Influence Cardiac Resynchronization Therapy Use and Outcome? (2015) (18)
- Quality of Care and Ischemic Stroke Risk After Hospitalization for Transient Ischemic Attack: Findings From Get With The Guidelines-Stroke (2015) (18)
- Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction. (2022) (17)
- Cluster-Randomized Trial of Personalized Site Performance Feedback in Get With The Guidelines-Heart Failure (2015) (17)
- Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG). (2011) (17)
- Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow. (2015) (17)
- The Obesity and Heart Failure Epidemics Among African Americans: Insights From the Jackson Heart Study. (2016) (17)
- Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation. (2020) (17)
- Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery. (2013) (17)
- Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease. (2016) (17)
- Highlights from the American Heart Association annual scientific sessions 2002: November 17 to 20, 2002. (2001) (17)
- Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial (2017) (16)
- Association of Electronic Health Record Use With Quality of Care and Outcomes in Heart Failure: An Analysis of Get With The Guidelines—Heart Failure (2018) (16)
- A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison's disease. (2013) (16)
- Clinical commentary on "Certain uncertainty: life after stroke from the patient's perspective". (2014) (16)
- Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial (2022) (16)
- Serum Bicarbonate in Acute Heart Failure: Relationship to Treatment Strategies and Clinical Outcomes. (2015) (16)
- 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness (2018) (16)
- Comparative effectiveness of angiotensin-converting-enzyme inhibitors: Is an ACE always an ace? (2008) (16)
- When academic research organizations and clinical research organizations disagree: Processes to minimize discrepancies prior to unblinding of randomized trials. (2017) (16)
- Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure (2021) (16)
- International Comparison of Patient Characteristics and Quality of Care for Ischemic Stroke: Analysis of the China National Stroke Registry and the American Heart Association Get With The Guidelines––Stroke Program (2018) (16)
- Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure (2017) (16)
- Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program. (2016) (16)
- Characteristics and outcomes of patients with heart failure and discordant findings by right-sided heart catheterization and cardiopulmonary exercise testing. (2014) (16)
- Clinical Effectiveness of Cardiac Resynchronization Therapy Versus Medical Therapy Alone Among Patients With Heart Failure (2014) (16)
- Sex and Age Interactions and Differences in Outcomes After Intracerebral Hemorrhage. (2017) (15)
- Regional differences in clinical profile, quality of care, and outcomes among Hispanic patients hospitalized with acute myocardial infarction in the Get with Guidelines-Coronary Artery Disease (GWTG-CAD) registry. (2011) (15)
- Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase. (2022) (15)
- Long‐term outcomes for heart failure patients with and without diabetes: From the Get With The Guidelines–Heart Failure Registry (2019) (15)
- The meanings associated with medicines in heart failure patients (2013) (15)
- Effect of Once‐Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial (2018) (15)
- Predictors of Incident Heart Failure Hospitalizations Among Patients With Impaired Glucose ToleranceClinical Perspective (2013) (15)
- Infectious complications in extended criteria heart transplantation. (2008) (15)
- Rapid Change in Prescribing Behavior in Hospitals Participating in Get With The Guidelines–Stroke After Release of the Management of Atherothrombosis With Clopidogrel in High-Risk Patients (MATCH) Clinical Trial Results (2010) (15)
- Early Ambulation Among Hospitalized Heart Failure Patients Is Associated With Reduced Length of Stay and 30-Day Readmissions (2018) (15)
- N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy (2017) (15)
- Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations. (2020) (15)
- Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy (2019) (15)
- Association of Implantable Device Measured Physical Activity With Hospitalization for Heart Failure. (2020) (15)
- Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week. (2022) (15)
- Quality of Care for Patients With Acute Coronary Syndromes as a Function of Hospital Revascularization Capability: Insights From Get With The Guidelines‐CAD (2014) (15)
- Association of Kidney Function With 30-Day and 1-Year Poststroke Mortality and Hospital Readmission: Get With The Guidelines-Stroke (2018) (15)
- Healthcare Resource Availability, Quality of Care, and Acute Ischemic Stroke Outcomes (2017) (14)
- Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry. (2018) (14)
- Cardiovascular events and hospital resource utilization pre– and post–transcatheter mitral valve repair in high–surgical risk patients (2017) (14)
- Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention (2015) (14)
- Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF). (2019) (14)
- Performance measures to promote quality improvement in sudden cardiac arrest prevention and treatment. (2013) (14)
- Acute decompensated heart failure patients admitted to critical care units: insights from ASCEND-HF. (2014) (14)
- Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF). (2018) (14)
- Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials (2016) (14)
- Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes. (2007) (14)
- Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized With Heart Failure and Reduced Ejection Fraction (2020) (14)
- Pharmacologic Prophylaxis for Venous Thromboembolism and 30‐Day Outcomes Among Older Patients Hospitalized With Heart Failure: An Analysis From the ADHERE National Registry Linked to Medicare Claims (2011) (14)
- Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry (2015) (14)
- Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues. (2019) (14)
- Outcomes Associated With Warfarin Use in Older Patients With Heart Failure and Atrial Fibrillation and a Cardiovascular Implantable Electronic Device: Findings From the ADHERE Registry Linked to Medicare Claims (2012) (13)
- Empagliflozin in Patients Post Myocardial Infarction Rationale and Design of the EMPACT-MI Trial. (2022) (13)
- Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF. (2013) (13)
- Development and validation of a risk model for in-hospital worsening heart failure from the Acute Decompensated Heart Failure National Registry (ADHERE). (2016) (13)
- Trends in Smoking Cessation Counseling: Experience From American Heart Association‐Get With The Guidelines (2012) (13)
- National Survey of Hospital Strategies to Reduce Heart Failure ReadmissionsClinical Perspective (2012) (13)
- Sex Differences in Clinical Course and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure. (2021) (13)
- 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report. (2021) (13)
- Hospital Factors Associated With Interhospital Transfer Destination for Stroke in the Northeast United States (2019) (13)
- Implementation of management strategies for diabetes and hypertension: from local to global health in cardiovascular diseases. (2015) (13)
- Left Atrial Structure and Function in Heart Failure with Preserved Ejection Fraction: A RELAX Substudy (2016) (12)
- Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF) - Phase I Evaluation of the Integration and Safety of the HeartLogic Multisensor Algorithm in Patients With Heart Failure. (2022) (12)
- Pulmonary Hypertension in the Era of Mechanical Circulatory Support (2016) (12)
- Hospital-based quality improvement interventions for patients with heart failure: a systematic review (2019) (12)
- Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. (2022) (12)
- Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). (2016) (12)
- The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes (2018) (12)
- Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction (2022) (12)
- 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report. (2021) (12)
- Biomarker Profile of Left Atrial Myopathy in Heart Failure with Preserved Ejection Fraction: Insights from the RELAX Trial. (2019) (11)
- Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights From ASCEND-HF. (2019) (11)
- Interaction of Body Mass Index on the Association Between N‐Terminal‐Pro‐b‐Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND‐HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) (2018) (11)
- Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale. (2016) (11)
- Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) (2019) (11)
- Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes. (2021) (11)
- Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients. (2019) (11)
- Age Differences in the Use of Implantable Cardioverter‐Defibrillators Among Older Patients Hospitalized with Heart Failure (2013) (11)
- PredischaRge initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial. (2020) (11)
- Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points: From the ASCEND-HF Trial (2018) (11)
- Characteristics of Acute Heart Failure Hospitalizations Based on Presenting Severity: Findings From the Get With the Guidelines–Heart Failure Registry (2019) (11)
- Characteristics, quality of care, and in-hospital outcomes of Asian-American heart failure patients: Findings from the American Heart Association Get With The Guidelines-Heart Failure Program. (2015) (11)
- Evaluation of a provocative dyspnea severity score in acute heart failure. (2016) (11)
- Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice. (2011) (11)
- Use of Renin–Angiotensin System Blockers in Acute Coronary Syndromes: Findings From Get With the Guidelines-Coronary Artery Disease Program (2012) (11)
- Finerenone in heart failure: walking a fine line. (2016) (11)
- Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). (2017) (11)
- Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease. (2018) (10)
- A Hospital Level Analysis of 30‐Day Readmission Performance for Heart Failure Patients and Long‐Term Survival: Findings from Get With The Guidelines‐Heart Failure (2018) (10)
- Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry. (2021) (10)
- Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review. (2021) (10)
- Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF) (2016) (10)
- Trends in Treatment for Patients Hospitalized with Heart Failure with Preserved Ejection Fraction Before and After Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT). (2020) (10)
- Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency (2021) (10)
- Management of newly treated diabetes in Medicare beneficiaries with and without heart failure (2017) (10)
- Association Between Switching to a High-Deductible Health Plan and Major Cardiovascular Outcomes (2020) (10)
- Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a protocol amendment. (2015) (10)
- Hemoglobin and Clinical Outcomes in the VerICiguaT Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA). (2021) (10)
- Impact of an Expanded Hospital Recognition Program for Stroke Quality of Care (2017) (10)
- Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure). (2019) (10)
- TRENDS IN THE CARE AND OUTCOMES OF MEDICARE BENEFICIARIES WITH TYPE 2 DIABETES, 2002-2011. (2016) (10)
- Highlights from the American College of Cardiology Annual Scientific Sessions 2003: March 28 to April 2, 2003. (2003) (10)
- Clinical Outcomes at 180 days in the ASCEND-HF Trial: Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (2011) (10)
- 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging—Best Practices for Safety and Effectiveness, Part 2: Radiological Equipment Operation, Dose‐Sparing Methodologies, Patient and Medical Personnel Protection (2018) (10)
- Improving Care for Patients after Hospitalization with Acute Kidney Injury. (2020) (10)
- Intra-Aortic Balloon Pump Use Before Left Ventricular Assist Device Implantation: Insights From the INTERMACS Registry (2018) (10)
- Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (2019) (10)
- Medical Therapy During Hospitalization for Heart Failure with Reduced Ejection Fraction: The VICTORIA Registry: Medical Therapy During Hospitalization for HFrEF. (2022) (9)
- The association between meteorological events and acute heart failure: new insights from ASCEND-HF. (2014) (9)
- Trends and outcomes of cardiac transplantation from donors dying of drug intoxication (2018) (9)
- Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial (2019) (9)
- Engaging patients throughout the health system: A landscape analysis of cold-call policies and recommendations for future policy change (2018) (9)
- Impact of an Expanded Hospital Recognition Program for Heart Failure Quality of Care (2014) (9)
- Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL (2019) (9)
- Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function. (2017) (9)
- Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial (2018) (9)
- History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure. (2019) (9)
- Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure (2013) (9)
- Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy (2019) (9)
- Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial (2022) (9)
- Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials (2021) (9)
- Clinical effectiveness of anticoagulation therapy among older patients with heart failure and without atrial fibrillation: findings from the ADHERE registry linked to Medicare claims. (2013) (9)
- Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale. (2020) (9)
- Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy. (2017) (9)
- Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. (2016) (9)
- Timing of Postdischarge Follow‐Up and Medication Adherence Among Patients With Heart Failure (2018) (9)
- Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry (2018) (9)
- Relationship Between Hospital Characteristics and Early Adoption of Angiotensin‐Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure (2019) (9)
- Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients (2016) (9)
- Same-day discharge and risks of mortality and readmission after elective ICD placement for primary prevention. (2015) (9)
- Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction (9)
- Thrombolytic therapy in older acute ischemic stroke patients with gastrointestinal malignancy or recent bleeding (2020) (8)
- National Hospital Quality Rankings: Improving the Value of Information in Hospital Rating Systems. (2020) (8)
- Renal Dysfunction in Heart Failure with Preserved Ejection Fraction: Insights from the RELAX Trial. (2020) (8)
- Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial. (2018) (8)
- A HOSPITAL LEVEL ANALYSIS OF 30-DAY READMISSION RATES FOR HEART FAILURE PATIENTS AND LONG-TERM SURVIVAL AMONG HIGHEST AND LOWEST PERFORMING HOSPITALS, FINDINGS FROM GET WITH THE GUIDELINES-HEART FAILURE (2017) (8)
- Completion of Guideline‐Recommended Initial Evaluation of Atrial Fibrillation (2012) (8)
- Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus. (2019) (8)
- Obstructive Sleep Apnea and Postoperative Outcomes (2011) (8)
- Prediction is very hard, especially about the future: comment on "factors associated with 30-day readmission rates after percutaneous coronary intervention". (2012) (8)
- Ischemic Stroke Transfer Patterns in the Northeast United States. (2019) (8)
- Strict Versus Lenient Versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure (from the Get With The Guidelines - Heart Failure Program). (2019) (8)
- Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction (2022) (8)
- Heart failure medications prescribed at discharge for patients with left ventricular assist devices. (2016) (8)
- PROVIDE-HF primary results: Patient-reported outcomes inVestigation following initiation of drug therapy with Entresto (Sacubitril/valsartan) in heart failure. (2020) (8)
- Priorities for Comparative Effectiveness Reviews in Cardiovascular Disease (2013) (8)
- Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease. (2009) (8)
- Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials (2020) (8)
- Testing for Coronary Artery Disease in Older Patients With New-Onset Heart Failure (2020) (8)
- Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy (2017) (8)
- Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. (2023) (7)
- Transmethylamine‐N‐Oxide Is Associated With Diffuse Cardiac Fibrosis in People Living With HIV (2021) (7)
- B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry. (2012) (7)
- The Need for Multiple Measures of Hospital QualityClinical Perspective (2011) (7)
- Interleukin-6 and Outcomes in Acute Heart Failure: An ASCEND-HF Sub-Study. (2021) (7)
- Differences in health care use and outcomes by the timing of in-hospital worsening heart failure. (2015) (7)
- OUTCOMES OF MEDICARE BENEFICIARIES WITH HEART FAILURE AND ATRIAL FIBRILLATION (2013) (7)
- Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial. (2016) (7)
- Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes (2020) (7)
- Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial (2022) (7)
- Improvement in Left Ventricular Ejection Fraction in Outpatients With Heart Failure With Reduced Ejection Fraction (2020) (7)
- Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting (2020) (7)
- Dapagliflozin for heart failure according to body mass index: the DELIVER trial (2022) (7)
- Incidence of statin use in older adults with and without cardiovascular disease and diabetes mellitus, January 2008- March 2018 (2019) (7)
- Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients. (2019) (6)
- Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromes. (2007) (6)
- Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score. (2016) (6)
- Dysphagia in the setting of left ventricular assist device hemolysis. (2013) (6)
- Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial (2019) (6)
- Generating evidence for therapeutic effects: the need for well-conducted randomized trials. (2020) (6)
- Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial (2021) (6)
- Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS‐HF (2020) (6)
- Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End PointsCLINICAL PERSPECTIVE (2016) (6)
- Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals (2019) (6)
- Participation in a Heart Failure Clinical Trial (2021) (6)
- Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial FibrillationCLINICAL PERSPECTIVE (2016) (6)
- Association between sacubitril/valsartan initiation and real‐world health status trajectories over 18 months in heart failure with reduced ejection fraction (2020) (6)
- The Association of Black Cardiologists (ABC) Cardiovascular Implementation Study (CVIS): A Research Registry Integrating Social Determinants to Support Care for Underserved Patients (2019) (6)
- Eligibility of sodium–glucose co‐transporter‐2 inhibitors among patients with diabetes mellitus admitted for heart failure (2019) (6)
- Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance (2019) (5)
- Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction (2020) (5)
- Preventing heart failure. (2013) (5)
- Net‐clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more (2019) (5)
- Design and rationale of a retrospective clinical effectiveness study of aldosterone antagonist therapy in patients with heart failure. (2012) (5)
- The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP‐HF (2022) (5)
- Early impact of guideline publication on angiotensin‐receptor neprilysin inhibitor use among patients hospitalized for heart failure (2018) (5)
- Abstract 9181: Does a Low Ejection Fraction Predict Mortality? Insights From the ASCEND-HF Trial (2012) (5)
- Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction. (2022) (5)
- Efficacy and safety of nesiritide in patients with acute decompensated heart failure (2010) (5)
- Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure: Analysis of the LIFE Trial Run-In. (2022) (5)
- The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey (2020) (5)
- The Potential Impact of Expanding Cardiac Rehabilitation in Heart Failure. (2016) (5)
- Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial (2022) (5)
- Associations Between Anticoagulation Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Atrial Fibrillation (2014) (5)
- Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) (2019) (5)
- Growth differentiation factor‐15, treatment with liraglutide, and clinical outcomes among patients with heart failure (2021) (5)
- Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical Trial. (2022) (5)
- Improving Care for Patients after Hospitalization with AKI (2020) (5)
- Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: A randomized, multicenter, placebo-controlled trial (HERO-HCQ) (2021) (5)
- 1896 IMPACT OF EXTENDED (E) VERSUS STANDARD LYMPH NODE DISSECTION (SLND) ON POST-CYSTECTOMY SURVIVAL (PCS) AMONG PATIENTS WITH LN-NEGATIVE UROTHELIAL BLADDER CANCER (UBC) (2011) (5)
- Heart Failure Clinical Trial Operations During the COVID-19 Pandemic (2020) (5)
- Paving a Better Path for Patients Dying of Heart Disease. (2018) (5)
- Achieving More Rapid Door-to-Needle Times and Improved Outcomes in Acute Ischemic Stroke in a Nationwide Quality Improvement Intervention (2021) (5)
- Rationale and Design of the Aldosterone Targeted NeuroHormonal CombinEd with Natriuresis TherApy in Heart Failure (ATHENA-HF) Trial (2016) (5)
- Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial (2021) (4)
- Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities. (2021) (4)
- TEMPORAL TRENDS IN CARDIAC REHABILITATION REFERRAL AMONG PATIENTS HOSPITALIZED WITH HEART FAILURE: ANALYSIS FROM AMERICAN HEART ASSOCIATION GET WITH THE GUIDELINES-HEART FAILURE REGISTRY (2015) (4)
- Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial. (2022) (4)
- Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months (2020) (4)
- Outcomes and cost among Medicare beneficiaries hospitalized for heart failure assigned to accountable care organizations. (2020) (4)
- PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized with Heart Failure. (2019) (4)
- Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes (2018) (4)
- Abstract 20393: Full-Dose Betrixaban Reduces Venous Thromboembolism-Related Mortality: An APEX Trial Substudy (2017) (4)
- Engagement, Research, and Evidence: Leveraging the National Patient-Centered Clinical Research Network for Better Cardiovascular Health. (2017) (4)
- Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure? (2019) (4)
- Characterization of hemodynamically stable acute heart failure patients requiring a critical care unit admission: Derivation, validation, and refinement of a risk score (2017) (4)
- Associations Between Blood Pressure and Outcomes Among Blacks in the Jackson Heart Study (2016) (4)
- Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes Model. (2021) (4)
- Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights From the EXSCEL Trial (2017) (4)
- Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure. (2020) (4)
- Postdischarge International Normalized Ratio Testing and Long‐term Clinical Outcomes of Patients With Heart Failure Receiving Warfarin: Findings From the ADHERE Registry Linked to Medicare Claims (2013) (4)
- Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes. (2017) (4)
- Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platform (2021) (4)
- Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial (2022) (4)
- Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors over Time in Heart Failure with Reduced Ejection Fraction. (2021) (4)
- Racial/Ethnic Disparities in Healthcare Worker Experiences During the COVID-19 Pandemic: An Analysis of the HERO Registry (2022) (4)
- Prescribing warfarin at discharge for heart failure patients: findings from the Get With The Guidelines-Heart Failure Registry. (2014) (4)
- DIABETIC PATIENTS HAVE SIMILAR VEIN GRAFT FAILURE AT 1 YEAR, BUT HIGHER 5-YEAR MORTALITY THAN NON-DIABETIC PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY: INSIGHTS FROM THE PREVENT-IV TRIAL (2012) (4)
- Disparate quality of care for black and hispanic heart failure (HF) patients: A report from Get With the Guidelines-Heart Failure (GWTG-HF) (2007) (4)
- Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry (2021) (3)
- Early Diuretic Strategies and the Association With In-Hospital and Post-Discharge Outcomes in Acute Heart Failure. (2021) (3)
- Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS‐CoV‐2 infection (2021) (3)
- Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP‐HF (2022) (3)
- Considerations for using distributed research networks to conduct aspects of randomized trials (2020) (3)
- When Should Patients Be Involved in Cardiovascular Clinical Trial Design?: Always, Early, and Often. (2017) (3)
- The use of electronic health records for recruitment in clinical trials: a mixed methods analysis of the Harmony Outcomes Electronic Health Record Ancillary Study (2021) (3)
- Chest pain in patients with heart failure: why history may matter. (2014) (3)
- Plasma Volume Status and its Association with In-Hospital and Post-Discharge Outcomes in Decompensated Heart Failure. (2020) (3)
- Advances in Heart Failure Mechanisms of Bleeding and Approach to Patients With Axial-Flow Left Ventricular Assist Devices (2011) (3)
- Patterns and Predictors of Discharge Statin Prescription Among Hospitalized Patients With Intracerebral Hemorrhage (2010) (3)
- Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis (2020) (3)
- Quality and Outcomes in Heart Failure (2020) (3)
- Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial (2019) (3)
- 5257Effects of once-weekly exenatide on clinical outcomes in the subgroup of patients with pre-existing cardiovascular disease: insights from EXSCEL (2018) (3)
- A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF) (2020) (3)
- Abstract 19325: Betrixaban Reduces the Burden of Multiple Symptomatic Venous Thromboembolic Events in the APEX Trial (2016) (3)
- Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ) (2023) (3)
- Abstract 3466: Hypertension Treatment and Control Among Patients Hospitalized with Heart Failure: An Analysis of Get With The Guidelines Heart Failure (2007) (3)
- Advancing care for acute heart failure—no time to relax (2009) (3)
- Abstract 252: PredischaRge Initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial (2019) (3)
- THE ROLE OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS) IN PATIENTS WITH A LEFT VENTRICULAR ASSIST DEVICE (LVAD): A SYSTEMATIC REVIEW AND META-ANALYSIS (2016) (3)
- Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials (2021) (3)
- Cardiac transplantation at Duke University Medical Center. (2004) (3)
- Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT‐HF risk model (2021) (3)
- Influence of Diuretic Dose and Route of Administration on Loop Diuretic Efficiency: Insights from the Diuretic Optimization Strategies Evaluation in Acute Heart Failure (DOSE-AHF) Trial (2014) (3)
- DO COUNTRIES OR HOSPITALS WITH LONGER STAYS HAVE LOWER READMISSION RATES? FINDINGS FROM THE ASCEND-HF TRIAL (2012) (3)
- Representativeness of Medicare Participants in the Jackson Heart Study for African American Medicare Beneficiaries (2017) (3)
- Sparing a little may save a lot: lessons from the Studies of Left Ventricular Dysfunction (SOLVD). (2003) (3)
- Dapagliflozin, atrial fibrillation, and heart failure with mildly reduced or preserved ejection fraction in DELIVER. (2022) (3)
- ESICM LIVES 2016: part three : Milan, Italy. 1-5 October 2016. (2016) (3)
- Identifying Treatments for Stage C2 Heart Failure. (2021) (3)
- Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial (2022) (3)
- Relationship between Hospital 30-Day Mortality Rates for Heart Failure and Patterns of Early Inpatient Comfort Care (2018) (3)
- Rapid change in prescribing behavior in hospitals participating in Get With the Guidelines- Stroke after release of the MATCH clinical trial results (2007) (3)
- Comparative Effectiveness of -Blockers in Elderly Patients With Heart Failure (2017) (2)
- Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial (2021) (2)
- 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging—Best Practices for Safety and Effectiveness, Part 1: Radiation Physics and Radiation Biology (2018) (2)
- Elevated Heart Rate in Patients with Heart Failure with Reduced Ejection Fraction: Associations with One-Year Survival and Costs (2015) (2)
- Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors (2021) (2)
- Impact of the COVID-19 Pandemic on Cardiovascular Science: Anticipating Problems and Potential Solutions: A Presidential Advisory From the American Heart Association. (2021) (2)
- Absence of July Phenomenon in Acute Ischemic Stroke Care Quality and Outcomes (2018) (2)
- TIMING AND CLINICAL PREDICTORS OF EARLY VERSUS LATE READMISSION AMONG PATIENTS HOSPITALIZED FOR ACUTE HEART FAILURE: INSIGHTS FROM ASCEND-HF (2017) (2)
- Abstract 18245: Results of the Chronic Heart Failure Intervention to Improve Medication Adherence (CHIME) Study: A Randomized Self-Management Intervention in High Risk Non-Adherent Patients (2013) (2)
- vte Prevention in Acutely Ill Medical Patients with Extended Duration Betrixaban - A Multicenter, Randomized, Active-controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Standard of Care Enoxaparin : ca02 (2016) (2)
- Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial. (2021) (2)
- USE AND COMPARATIVE EFFECTIVENESS OF CARDIAC RESYNCHRONIZATION THERAPY AMONG PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION: DATA FROM THE NCDR® REGISTRY (2014) (2)
- Admission, Discharge, or Change in BNP and Long-Term Mortality: Data from OPTIMIZE-HF Linked with Medicare Claims (2010) (2)
- PROVIDE-HF STUDY RESULTS: PATIENT-REPORTED OUTCOMES INVESTIGATION FOLLOWING INITIATION OF DRUG THERAPY WITH ENTRESTO (SACUBITRIL/VALSARTAN) IN HEART FAILURE (2020) (2)
- Abstract 203: Health Status Variations Across Practices in Outpatients With Heart Failure: Health Status Variations Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF Registry (2018) (2)
- Left Ventricular Assessment in Myocardial Infarction (2013) (2)
- Abstract P35: Mild or Improving Stroke is the Most Frequently Documented Reason for Not Giving rt-PA in Time-Eligible Acute Ischemic Stroke Patients: Findings From Get With the Guidelines-Stroke (2011) (2)
- Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome. (2022) (2)
- Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial. (2023) (2)
- Time to intravenous therapy and clinical outcomes in older patients presenting with acute decompensated heart failure: an analysis of the adhere registry emergency module (2013) (2)
- RELIABLE EVALUATION OF DYSPNEA (RED-ROSE): A PROSPECTIVE ANCILLARY STUDY FROM THE RENAL OPTIMIZATION STRATEGIES EVALUATION IN ACUTE HEART FAILURE (ROSE-AHF) TRIAL (2014) (2)
- Impact of SGLT2 Inhibitors (SGLT2i) on Cardiovascular (CV) Risk and Estimated Glomerular Filtration Rate (eGFR) in the EXSCEL Placebo Group (2018) (2)
- Abstract 02: Does Pokemon Go Help Players be More Active? An Evaluation of Pokemon Go and Physical Activity (2017) (2)
- POSTOPERATIVE GLUCOSE CONTROL FOLLOWING CORONARY ARTERY BYPASS GRAFT SURGERY: PREDICTORS AND CLINICAL OUTCOMES (2013) (2)
- ASSOCIATION BETWEEN SERUM POTASSIUM LEVEL AND OUTCOMES IN HEART FAILURE WITH REDUCED EJECTION FRACTION: A COHORT STUDY FROM THE SWEDISH HEART FAILURE REGISTRY (2017) (2)
- What Is Needed Now to Improve Cardiovascular Clinical Registries in the Future. (2019) (2)
- The impact of COVID-19 on pragmatic clinical trials: lessons learned from the NIH Health Care Systems Research Collaboratory (2022) (2)
- Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial. (2018) (2)
- Correlation between peak expiratory flow rate and NT-proBNP in patients with acute heart failure. An analysis from ASCEND-HF trial. (2015) (2)
- PATIENTS WITH DIABETES AND PERIPHERAL ARTERIAL DISEASE: RESULTS FROM THE EXSCEL TRIAL (2019) (2)
- Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes? (2018) (2)
- Abstract 50: Shape of the TPA Time - Benefit Curve: Insights From The National US Get With The Guidelines - Stroke Population (2015) (2)
- Response by Kumbhani et al to Letters Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure". (2018) (2)
- Abstract 12658: Humoral Activation in Decompensated Heart Failure with Preserved or Reduced Ejection Fraction (2010) (2)
- Embolic myocardial infarction in atrial fibrillation: multiple territory injury revealed by cardiac magnetic resonance (2010) (2)
- Abstract 86: Progress in Achieving More Rapid Door-to-Needle Times in Acute Ischemic Stroke: Interim Findings From Target: Stroke Phase II (2017) (2)
- Abstract 2947: Evolving Patterns of Use of Aldosterone Inhibition in Chronic Heart Failure; A Report from Get with the Guidelines HF (2008) (2)
- Admission, Discharge, or Change in BNP and Long-Term Outcomes: Data from OPTIMIZE-HF Linked to Medicare Claims (2011) (2)
- Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR‐TIMI 53 cardiovascular outcomes trials (2020) (2)
- Topical anesthesia with EMLA reduces pain during endomyocardial biopsy: a randomized trial. (2006) (2)
- Expected vs Actual Outcomes of Elective Initiation of Inotropic Therapy During Heart Failure Hospitalization (2020) (2)
- Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients with HFrEF: Results from the CONNECT-HF Trial. (2022) (2)
- Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial. (2021) (2)
- Abstract 15500: Dabigatran is Associated with Higher Risk of Myocardial Infarction or Acute Coronary Syndromes: a Meta-analysis of Non-Inferiority Randomized Controlled Trials (2011) (2)
- Cortical and subcortical grey matter morphometry for neuroprognostication after cardiac arrest (2016) (2)
- Dysglycemia and Incident Heart Failure among Blacks: The Jackson Heart Study. (2021) (2)
- Influence of the American Heart Association's Get With The Guidelines (GWTG) Program on the Quality of Care for Patients Hospitalized with Heart Failure (2006) (2)
- LONGITUDINAL CHANGES IN MEDICATION DOSING AMONG PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: FROM THE CHAMP-HF REGISTRY (2019) (2)
- Subcutaneous Furosemide in the Treatment of Patients with Decompensated Heart Failure: Data from the Sub-Q Pilot Studies (2019) (2)
- Lack of Improvement in 30-day Readmission Rates for Patients Hospitalized with Heart Failure: Data from Get With The Guidelines-Heart Failure Registry (2015) (2)
- Association of post‐vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high‐risk cardiovascular disease: the INVESTED trial (2022) (2)
- Evaluating the Application of Chronic Heart Failure Therapies and Developing Treatments in Individuals With Recent Myocardial Infarction: A Review. (2022) (2)
- Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction. (2022) (2)
- Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid–Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout (2023) (2)
- Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan (2022) (2)
- 4321Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial (2018) (2)
- Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of Vericiguat. (2022) (2)
- Combined Use of Warfarin and Oral P2Y12 Inhibitors in Patients With Atrial Fibrillation and Acute Coronary Syndrome (2014) (2)
- Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER (2022) (2)
- Abstract 4348: Quality of Acute Myocardial Infarction Care and Outcomes in 33,997 Patients Aged 80 Years or Older: Results From GWTG-CAD (2009) (1)
- Abstract 20444: Betrixaban Reduces Not Only the Presence of Thrombus but Also Extent of Thrombus: An APEX Trial Substudy (2017) (1)
- BASELINE CARDIAC TROPONIN T, CLINICAL OUTCOMES AND VERICIGUAT TREATMENT EFFECT IN HEART FAILURE WITH REDUCED EJECTION FRACTION STUDY: INSIGHTS FROM THE VICTORIA TRIAL (2021) (1)
- Haemoconcentration during treatment of acute heart failure with cardiorenal syndrome: from the CARRESS‐HF trial (2019) (1)
- NT-PROBNP IN ACUTE DECOMPENSATED HEART FAILURE: FINDINGS FROM THE ASCEND-HF STUDY (2013) (1)
- Abstract 342: Differences in Health Care Utilization and Outcomes Based on Timing of In-Hospital Worsening Heart Failure (2015) (1)
- Abstract 13246: Data Quality in the American Heart Association Get With the Guidelines-Stroke: Results from a National Data Validation Audit (2011) (1)
- Abstract 12509: Initial Reports on the Safety of Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke Patients Taking Novel Oral Anticoagulants (NOACs) (2015) (1)
- PCSK9 Inhibitor Use in the Real World: Data From the National Patient Centered Outcomes Research Network (PCORNet) (2018) (1)
- PLASMA ENDOTHELIN-1 INDEPENDENTLY PREDICTS 180-DAY MORTALITY IN ACUTE HEART FAILURE: AN ASCEND-HF SUB-STUDY (2015) (1)
- Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes (2022) (1)
- Abstract 142: Engaging Patients Throughout the Health System: A Landscape Analysis of Top Research Institutions and Cold Call Policies (2018) (1)
- 6-LB: Effect of Open-Label SGLT2 Inhibitor Treatment When Combined with Exenatide on Cardiovascular and Renal Outcomes in EXSCEL (2019) (1)
- Hemoglobin, anemia, and clinical outcomes in vericiguat global study in subjects with heart failure with reduced ejection fraction (VICTORIA) (2021) (1)
- POST DISCHARGE MANAGEMENT PROGRAMS FOR ELDERLY HEART FAILURE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS (2010) (1)
- Abstract 20322: Extended-Duration Betrixaban Reduces the Risk of Venous Thromboembolism-Related Rehospitalization Among Acutely Ill Hospitalized Medical Patients: An APEX Trial Substudy (2017) (1)
- The worst symptom visual analogue scale: a prospective ancillary study from the renal optimization strategies evaluation in acute heart failure (rose-AHF) trial (2014) (1)
- Periprocedural Risk and Survival after ICD Placement in Patients with Advanced Heart Failure (2018) (1)
- In heart failure, automatic implant-based telemonitoring reduced a composite of cardiac events and mortality (2014) (1)
- MARKERS OF CONGESTION, SYMPTOM RELIEF AND CLINICAL OUTCOMES AMONG PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE: DATA FROM THE DIURETIC OPTIMAL STRATEGY EVALUATION IN ACUTE HEART FAILURE STUDY (2011) (1)
- Evolving the Hospital Readmissions Reduction Program: A Call for Peace, Happiness, and Improved Patient-Centered Outcomes. (2019) (1)
- Response by Hess et al to Letter Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Program". (2017) (1)
- Estimated Event-Free Survival Benefits with Dapagliflozin in HF with Mildly Reduced or Preserved Ejection Fraction. (2022) (1)
- Medication-Attributable Adverse Events in Heart Failure Trials. (2023) (1)
- Maximizing benefits and mitigating risks with mineralocorticoid receptor antagonist therapy (2018) (1)
- Abstract WP312: The Association of Chronic Kidney Disease (CKD) With 30-day and 1-year Post Ischemic Stroke Mortality and Rehospitalization: Get With the Guidelines (GWTG) Stroke (2016) (1)
- Abstract 1580: Prediction of In-Hospital Mortality in Ischemic Stroke Using Data From Get With the Guidelines Stroke (2009) (1)
- IMPACT OF ATRIAL FIBRILLATION ON EXERCISE CAPACITY IN DIASTOLIC HEART FAILURE: A RELAX TRIAL ANCILLARY STUDY (2013) (1)
- P884Can biomarkers be used to predict cardiopulmonary exercise test performance in patients with chronic heart failure? (2018) (1)
- Abstract 13642: Hospitalist Care and Associated Outcomes for Patients Hospitalized with Heart Failure: Insights from Get With The Guidelines-Heart Failure (2011) (1)
- N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes (1)
- Ultrafiltration in heart failure with cardiorenal syndrome. (2013) (1)
- Response to Letter Regarding Article, “Mechanisms of Bleeding and Approach to Patients With Axial-Flow Left Ventricular Assist Devices” (2012) (1)
- P1623Association of low hemoglobin with venous thromboembolism in acutely ill hospitalized medical patients: findings from the APEX trial (2018) (1)
- The Use of Sacubitril/Valsartan for Hospitalized Heart Failure-Why Do We Care About Cost and Value? (2020) (1)
- Abstract 11118: Temporal Trends in Clinical Characteristics of Patients Without Known Coronary Artery Disease Presenting With a First Episode of Myocardial Infarction (2013) (1)
- Cardiovascular safety and efficacy of exenatide once-weekly in patients with moderate renal dysfunction in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) (2018) (1)
- Abstract 3993: Quality of Care for Heart Failure Patients with Concomitant Kidney Disease in the American Heart Association’s Get With The Guidelines Heart Failure (GWTG-HF) Program (2006) (1)
- Abstract 99: Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke in the National US GWTG-Stroke Population (2013) (1)
- Early Vasopressor Utilization Strategies and Outcomes in Critically Ill Patients With Severe Traumatic Brain Injury (2022) (1)
- From Theory to Practice: The Use of Real-World Data to Evaluate New Heart Failure Therapies. (2019) (1)
- The design and rationale for the APEX study (Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban) (2013) (1)
- Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure (1)
- Pooled RCTs: -blockers reduce mortality in heart failure patients with sinus rhythm but not in those with AF (2015) (1)
- What's Harder: Seeing a Doctor or Reducing Readmissions? (2015) (1)
- P251Asymptomatic deep vein thrombosis in acutely ill medical patients: insights from the APEX trial (2018) (1)
- Abstract TMP79: Use of Intravenous Tissue Plasminogen Activator in Patients With History of Prior Stroke Plus Diabetes Mellitus (2019) (1)
- , Among Patients With Heart Failure and Atrial Fibrillation Associations Between Anticoagulation Therapy and Risks of Mortality and Readmission (1)
- A centralised telephone intervention reduced combined all cause mortality or admission for worsening HF in chronic heart failure (2006) (1)
- Implications of Amiodarone Use Before Heart Transplantation (2016) (1)
- Abstract P113: Use of Guideline Recommended Therapies for Heart Failure in Outpatient Settings Among Medicare Beneficiaries (2011) (1)
- The Safety and Efficacy of Full Versus Reduced Dose Betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention with Extended Duration Betrixaban (APEX) Trial (2016) (1)
- Landscape of coronavirus disease 2019 clinical trials: New frontiers and challenges (2022) (1)
- Cystatin C as a Biomarker of Worsening Renal Function in Acute Heart Failure: Insights from the DOSE Study (2011) (1)
- Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial (2021) (1)
- ANTI-HYPERGLYCEMIC MEDICATION USE AMONG MEDICARE BENEFICIARIES WITH HEART FAILURE, DIABETES, AND CHRONIC KIDNEY DISEASE (2015) (1)
- Acute heart failure: nomenclature, pathophysiology, and outcome measures (2005) (1)
- Abstract 2740: Influence of the American Heart Association's Get with the Guidelines Heart Failure (GWTG-HF) Program on Emerging Performance Measures for Patients Hospitalized with Heart Failure (2006) (1)
- Does Guideline-Directed Medical Therapy for Heart Failure Offer Benefits After LVAD Placement?-A Call for a Randomized Clinical Trial. (2019) (1)
- Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction Spectrum. (2022) (1)
- Abstract 227: Aldosterone Antagonists in Post-Acute Myocardial Infarction Use, Predictors, and Temporal Trends of a Class I Recommendation (2012) (1)
- INCREASED RISK OF SEVERE HYPOGLYCEMIC EVENTS BEFORE AND AFTER CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES: VALIDATION OF A NOVEL CONCEPT (2019) (1)
- MINI-SENTINEL MEDICAL PRODUCT ASSESSMENT SIGNAL REFINEMENT OF ANGIOEDEMA EVENTS IN ASSOCIATION WITH USE OF DRUGS THAT ACT ON THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM REPORT (2017) (1)
- Digoxin initiation is associated with lower risk of all-cause readmission after hospitalisation for heart failure (2014) (1)
- CARE AND OUTCOMES OF ASIAN ACUTE MYOCARDIAL INFARCTION PATIENTS: RESULTS FROM THE AMERICAN HEART ASSOCIATION GET WITH THE GUIDELINES-CORONARY ARTERY DISEASE PROGRAM (2011) (1)
- Comparative Effectiveness of Primary Prevention Implantable Cardioverter‐Defibrillators in Older Heart Failure Patients With Diabetes Mellitus (2020) (1)
- Albuminuria and Heart Failure: JACC State-of-the-Art Review. (2023) (1)
- OUTCOMES OF NON-SURGICAL PATIENTS WITH SEVERE TRICUSPID REGURGITATION AND CONGESTIVE HEART FAILURE (2019) (1)
- 109Betrixaban compared to enoxaparin among obese acute medically ill subjects: an APEX trial subgroup analysis (2018) (1)
- The Association of Digital Health Application Use with Heart Failure Care and Outcomes: Insights from CONNECT-HF. (2022) (1)
- 2160Performance of a machine learning model vs. IMPROVE score for VTE prediction in acute medically ill patients: insights from the APEX trial (2018) (1)
- Abstract 3377: Right Ventricular Dysfunction in Recipients of Destination Therapy Left Ventricular Assist Devices versus Marginal-Donor Cardiac Allografts (2009) (1)
- Abstract 17368: Years of Life Lost Due to Heart Failure in the United States (US) (2015) (1)
- Abstract WP280: Use of Strategies to Improve Door-to-Needle Times with Tissue Plasminogen Activator in Acute Ischemic Stroke by US Hospitals: Findings from the Target: Stroke Survey (2013) (1)
- Abstract WMP34: Use of Intravenous Tissue Plasminogen Activator in Patients Without a Stroke (Stroke Mimics): Findings From the get With the Guidelines Stroke Registry (2016) (1)
- Abstract 19718: Incidence of Atrial Fibrillation and Associated Mortality among Medicare Beneficiaries from 1993 to 2007 (2010) (1)
- REGIONAL DIFFERENCES IN CLINICAL PROFILE, QUALITY OF CARE AND OUTCOMES AMONG HISPANIC PATIENTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTION IN THE GET WITH GUIDELINES-CORONARY ARTERY DISEASE REGISTRY (2011) (1)
- Abstract 19875: IMPROVEDD Score: Addition of D-Dimer to the IMPROVE Score Improves Venous Thromboembolism Risk Stratification. An APEX Trial Substudy (2016) (1)
- Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial (2018) (1)
- Abstract 12863: Sex Differences for Heart Failure Patients with Preserved and Reduced Systolic Function: Data from the American Heart Association Get With the Guidelines-Heart Failure (2011) (1)
- Novel Protein Glycan Inflammatory Biomarkers Predict Adverse Events in Heart Failure with Preserved Ejection Fraction (2015) (1)
- Quantitative Blood Volume Analysis and Hemodynamic Measures of Vascular Compliance in Patients with Worsening Heart Failure: BVA and Hemodynamic Profiles in Worsening HF. (2022) (1)
- Abstract 19403: Gender and Socioeconomic Disparities With Health Status in Outpatients With Heart Failure: Insights From the CHAMP-HF Registry (2017) (1)
- Iterative approaches to the use of electronic health records data for large pragmatic studies. (2022) (1)
- PARADOXICAL PROTECTIVE EFFECT OF OBESITY ON THE RISK OF VENOUS THROMBOEMBOLISM: OBSERVATIONS FROM APEX TRIAL (2019) (1)
- Abstract 115: Improving Door-to-Needle Times in Acute Ischemic Stroke: Interim Findings From Target: Stroke Phase II (2016) (1)
- Utilization and Outcomes of Extracorporeal Membrane Oxygenation Following Traumatic Brain Injury in the United States (2022) (1)
- A Stepwise Pharmacological Care Algorithm for Cardiorenal Syndrome for Acute Heart Failure: Insights from DOSE-AHF, CARRESS-HF, and ROSE-AHF (2014) (1)
- 141 STAGE MIGRATION IN PROSTATE CANCER AT RADICAL PROSTATECTOMY DURING THE PSA ERA IS ASSOCIATED WITH RELATIVELY CONSTANT GLEASON SCORE (2010) (1)
- Abstract 168: The ADHERE Risk Model for In-hospital Worsening Heart Failure (2015) (1)
- Effect Of Vericiguat In Victoria According To Guideline-directed Medical Therapy (2020) (1)
- Weekend Hospital Admission for Heart Failure: Influence on Quality of Care, Length of Stay, and In-Hospital Mortality (2008) (1)
- Abstract 4142: Metabolic Syndrome in Patients with CAD: Is it More than Obesity? Analysis of 79,677 Hospitalizations in Get with the Guidelines (2006) (1)
- Association between Sacubitril/Valsartan Initiation and Health Status Outcomes inHeart Failure with Reduced Ejection Fraction:Findings from the CHAMP-HF Registry (2018) (0)
- QUALITY OF CARE AND OUTCOMES AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CHRONIC RENAL INSUFFICIENCY: REPORT FROM THE GET WITH THE GUIDELINES PROGRAM (2011) (0)
- Abstract 266: No Impact of Electronic Health Records on Quality of Care and Outcomes for Ischemic Stroke (2014) (0)
- Consensus Statement Acute Decompensated Heart Failure: Update on New and Emerging Evidence and Directions for Future Research (2013) (0)
- Abstract 13344: Is Cardiac Resynchronization Therapy Use Improving Among Racial/Ethnic Minorities? An Analysis of 107,096 Patients from the NCDR-ICD Registry (2011) (0)
- Loop Diuretic Dose Adjustments After a Hospitalization for Heart Failure: Insights from ASCEND-HF (2014) (0)
- Abstract 10682: Is Acute Heart Failure Admission Linked to a Change in Temperature? Insights from ASCEND-HF (2011) (0)
- Abstract 206: Pre-notification by Emergency Medical Services is Associated with More Timely Evaluation and Treatment of Acute Ischemic Stroke (2012) (0)
- Abstract 15883: Home-Time as a Novel Post-Discharge Outcome for Patients Hospitalized With Heart Failure (2017) (0)
- Abstract P34: Hospital Level Variation in Clinical Outcomes for Medicare Beneficiaries Hospitalized With Ischemic Stroke (2011) (0)
- Omecamtiv mecarbil: Decisional Dilemmas & Regulatory Science - Opportunities for Improvement? (2023) (0)
- Use and Predictors of Heart Failure Disease Management Referral in Patients Hospitalized With Heart Failure: Insights from the American Heart Association – Get with the Guidelines Program (2010) (0)
- PREVALENCE, PREDICTORS AND EFFECTS OF NESIRITIDE ON CHANGES IN RENAL FUNCTION DURING HOSPITALIZATION FOR ACUTE DECOMPENSATED HEART FAILURE : RESULTS FROM ASCEND-HF (2013) (0)
- Abstract 17576: Readmission for Stroke and Quality of Care Among Patients Hospitalized With Transient Ischemic Attack (TIA): Findings From Get With the Guidelines (GWTG)-Stroke (2013) (0)
- Abstract 12031: Initiation, Continuation, or Withdrawal of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction (2016) (0)
- Abstract P188: Quality of Care and Outcomes in Women Hospitalized for Heart Failure (2011) (0)
- Abstract 17846: Weighing The Evidence: Geographic Variation And The Obesity Paradox In Patients With Acute Decompensated Heart Failure In The Ascend-hf Trial (2013) (0)
- Abstract 17: Racial and Ethnic Differences in Outcomes in Older Patients with Acute Ischemic Stroke (2013) (0)
- Abstract 8: Get With The Guidelines-Stroke Program Participation and Clinical Outcomes for Medicare Beneficiaries (2013) (0)
- Integrating Research With Clinical Practice: Keeping It Simple. (2017) (0)
- RESTING VENTRICULAR-VASCULAR FUNCTION AND EXERCISE CAPACITY IN DIASTOLIC HEART FAILURE (DHF): A RELAX TRIAL ANCILLARY STUDY (2013) (0)
- Abstract 9193: Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial: Findings From ASCEND-HF (2012) (0)
- RESTING HEART RATE AND LONG-TERM OUTCOMES IN AFRICAN AMERICANS: INSIGHTS FROM THE JACKSON HEART STUDY (2016) (0)
- Abstract 255: The Development of an Observational Registry of Treatment Patterns in US Heart Failure Patients with Reduced Ejection Fraction (HFrEF) (2016) (0)
- Abstract 17495: Achievement of Secondary Prevention Performance Measures in Patients with Coronary Artery Disease in Teaching and Non-Teaching Hospitals: Results from the Get With The Guidelines CAD Program (2010) (0)
- Statistical Code for Clinical Research Papers (2019) (0)
- Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation : Findings From the NCDR ICD Registry (2016) (0)
- Features and Hospital Outcomes for Nonadherent Patients with Heart Failure: Findings from GWTG-HF (2008) (0)
- ADJUSTMENT OF GUIDELINE-DIRECTED MEDICAL THERAPY ONE YEAR POST-HEART FAILURE HOSPITALIZATION FALLS SHORT: INSIGHTS FROM THE CONNECT-HF TRIAL (2023) (0)
- Abstract 12458: Mineralocorticoid Receptor Antagonist Use in Patients With Heart Failure and Co-Morbid Diabetes or Chronic Kidney Disease (2016) (0)
- Anticoagulation and Clinical Outcomes in Heart Failure Patients With Atrial Fibrillation: Findings From the ADHERE Registry. (2013) (0)
- Abstract 15973: The Association Between Blood Pressure Control and Outcomes Among Black Participants in the Jackson Heart Study (2015) (0)
- External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial (2022) (0)
- Potential impact of differential drop-in of open-label diabetes medications in EXSCEL (2018) (0)
- Venous Thromboembolism Prophylaxis among Elderly Heart Failure Patients and 60-Day Outcomes: An Analysis from ADHERE Linked to Medicare Claims (2010) (0)
- Abstract WP372: International Comparison of Patient Characteristics and Quality of Care for Ischemic Stroke (2019) (0)
- Editorial Board (1982) (0)
- PREDICTORS OF DEFECT-FREE COMPLIANCE WITH PROCESS MEASURES IN PATIENTS PRESENTING WITH ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM GET WITH THE GUIDELINES CAD (2011) (0)
- PROGNOSTIC VALUE OF RIGHT-SIDED VOLUME OVERLOAD IN PATIENTS PRESENTING WITH ACUTE HEART FAILURE: INSIGHTS FROM ASCEND-HF (2016) (0)
- Abstract 19675: Testing Strategies and Poor Outcomes of Syncope among Medicare Beneficiaries (2014) (0)
- Making Every Mobile Heart Count! (2017) (0)
- Risks and Benefits AssociatedWith Prestroke Antiplatelet Therapy Among PatientsWith Acute Ischemic Stroke TreatedWith Intravenous Tissue Plasminogen Activator (2016) (0)
- BNP-guided heart failure therapy in older patients. (2009) (0)
- Assessing the Quality and Comparative of Team-Based Care for Heart Failure Who, What, Where, When, and How (2015) (0)
- Abstract 18919: Race/Ethnic Differences in Mortality Among Patients Hospitalized with Intracerebral Hemorrhage (2012) (0)
- Abstract 17419: Sex and Race Related Disparities in Care and Outcomes After Hospitalization for Coronary Artery Disease Among Older Adults (2015) (0)
- Assessing the Impact of the American Heart Association’s Research Portfolio: A Scientific Statement From the American Heart Association (2022) (0)
- PROGNOSTIC VALUE OF BASELINE AND CHANGES IN CIRCULATING SOLUBLE ST2 LEVELS AND THE EFFECTS OF NESIRITIDE IN ACUTE DECOMPENSATED HEART FAILURE (2015) (0)
- 186 Long Term Mechanical Circulatory Support: What Are the Final Options? (2012) (0)
- Abstract 3023: The Association of Insurance Status, Quality of Care, and In-Hospital Outcomes among Patients Hospitalized with Intracerebral Hemorrhage: Findings from GWTG-Stroke (2012) (0)
- Admission Heart Rate and In-Hospital Outcomes in Patients Hospitalized for Heart Failure in Sinus Rhythm and Atrial Fibrillation (2012) (0)
- EARLY PHYSICIAN FOLLOW-UP AND 30-DAY READMISSION AMONG MEDICARE BENEFICIARIES HOSPITALIZED WITH HEART FAILURE: DATA FROM OPTIMIZE-HF AND GWTG-HF (2010) (0)
- Data Sharing Goals for Nonprofit Funders of Clinical Trials (2021) (0)
- MODE OF DEATH FOR MEN AND WOMEN WITH ACUTE HEART FAILURE ACROSS THE SPECTRUM OF EJECTION FRACTION: FROM THE ASCEND-HF TRIAL (2021) (0)
- Abstract 19208: Extended Duration Betrixaban Reduces the Risk of Stroke vs Standard Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Substudy (2016) (0)
- Abstract TMP39: Patterns of Discharge Antidepressant Therapy Use After Acute Ischemic Stroke: Insights From the Prosper Study (2018) (0)
- Clinical Characteristics and Outcomes of Patients with Discordant Findings at Right Heart Catheterization and Cardiopulmonary Exercise Testing (2014) (0)
- Association between VE-VCO2 Slope and Resting Hemodynamic Measurements in Ambulatory Heart Failure (HF) Patients: An Analysis from the Duke Advanced HF Database (2011) (0)
- Translating evidence into practice: use of statins in real-world patients with heart failure. (2008) (0)
- Abstract 19100: Medication Initiation Burden Required to Comply with Hospital Quality Measures for Heart Failure (2014) (0)
- Abstract 109: In-Hospital Worsening Heart Failure is Associated With Poor Patient Outcomes and Increased Health Care Utilization (2014) (0)
- Randomized Clinical Trials in HFpEF (2012) (0)
- The challenges of data safety monitoring for a pragmatic study: Lessons from the ADAPTABLE study. (2022) (0)
- Abstract 10131: Baseline Characteristics, Quality of Care, and Short-Term outcomes of Young Patients Presenting with ST-Segment Elevation Myocardial Infarction: Insight from the Get With the Guidelines CAD Registry (2010) (0)
- Hoping for the best while preparing for the worst: Communication about end-of-life planning in Heart Transplant Programs (2005) (0)
- Laboratory Monitoring after Inpatient and Outpatient Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients with Heart Failure (2016) (0)
- Abstract 16707: High versus Low-to-Moderate Intensity Statin Treatment and One-Year Clinical Outcomes Among Older Patients With Coronary Artery Disease (2014) (0)
- 2008 IDENTIFICATION OF VARIABLES ASSOCIATED WITH INCREASED PAIN DURING TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY (2010) (0)
- Abstract 11: Use of Novel Anticoagulants Among Atrial Fibrillation Patients Hospitalized with Ischemic Stroke or Transient Ischemic Attack: A Get With The Guidelines-Stroke Registry Analysis (2013) (0)
- Abstract 18707: Do Patients with Heart Failure and Atrial Fibrillation Adhere to Warfarin After Hospital Discharge? Findings from the Get With The Guidelines-Heart Failure Registry and Medicare Linked Database (2012) (0)
- Non-participation in a Heart Failure Clinical Trial: Perspectives and Opportunities from the VICTORIA Trial and Simultaneous Registry (2020) (0)
- DIFFERENCES IN THERAPY AND DECONGESTION BETWEEN MEN AND WOMEN HOSPITALIZED FOR ACUTE HEART FAILURE: FINDINGS FROM ASCEND-HF (2020) (0)
- Abstract 214: Strict versus Lenient versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure: Findings From the Get With the Guidelines - Heart Failure Program (2018) (0)
- Abstract 30: Door-to-puncture and First Pass Times for Endovascular Thrombectomy: Predictors and Changes Over Time in GWTG-stroke (2017) (0)
- Improving heart failure health: is there a secret Swedish sauce? (2017) (0)
- Abstract 14073: Trajectory of Congestion Metrics by Ejection Fraction in Acute Heart Failure - Findings From the Heart Failure Network (2016) (0)
- Review: In noncardiac surgery, amiodarone, -blocker, or statin prophylaxis reduces postoperative AF (2018) (0)
- Abstract 165: Age Related Variations in Improvement in Door-to-Needle Times in Acute Ischemic Stroke: Findings From Target: Stroke Phase I (2016) (0)
- C-REACTIVE PROTEIN IN ACUTE DECOMPENSATED HEART FAILURE: INSIGHTS FROM ASCEND-HF (2013) (0)
- Abstract WMP85: Clinical Effectiveness of Direct Oral Anticoagulants (DOACs) vs. Warfarin in Older Ischemic Stroke Patients With Atrial Fibrillation: Findings From Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study (2019) (0)
- Abstract P112: End-of-Life Care in Heart Failure: Differences Between the U.S. and Canada (2011) (0)
- Abstract WP375: Quality of Care and In-Hospital Outcomes by Race and Ethnicity among Patients Hospitalized with Intracerebral Hemorrhage: Findings from 123,623 Patients in the Get With The Guidelines-Stroke Program (2013) (0)
- Abstract 17114: Whose Work is It? Patient Perspectives on Challenges in Heart Failure Self-Management (2020) (0)
- Use of Target Doses of Guideline Directed Medical Therapy in Heart Failure by Systolic Blood Pressure: Insights from the CHAMP-HF Registry (2018) (0)
- 130 Extended Criteria Cardiac Transplantation Versus Destination Therapy Left Ventricular Assist Device Therapy in the Continuous Flow Era (2012) (0)
- PREDICTORS OF 30-DAY READMISSION IN PATIENTS WITH SYNCOPE (2018) (0)
- Abstract 18407: Identifying Patients With Acute Heart Failure who Require a Critical Care Admission: ASCEND-HF Insights (2015) (0)
- Abstract 278: Trends in Prescribing Patterns for Patients Hospitalized With Heart Failure With Preserved Ejection Fraction Before and After Clinical Trial Presentation (2018) (0)
- Reliability of Heart Failure Patient Care: Initial Results from the American Heart Association's Get With The Guidelines (GWTG) Heart Failure Program (2006) (0)
- METABOLOMIC PROFILING IDENTIFIES BIOMARKERS PREDICTING ADVERSE OUTCOMES IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (2015) (0)
- COMPARATIVE EFFECTIVENESS OF CARDIAC RESYNCHRONIZATION THERAPY WITH DEFIBRILLATOR VERSUS DEFIBRILLATOR ALONE IN HEART FAILURE PATIENTS WITH MODERATE TO SEVERE CHRONIC KIDNEY DISEASE (2015) (0)
- Improved Clinical Outcomes in Medicare Beneficiaries with Acute Ischemic Stroke during Initial Implementation of the Get with the Guidelines-Stroke Program 2003-2008 (IN2-2.002) (2012) (0)
- IMPACT OF SEVERE DYSPNEA ON OUTCOMES AND HEALTH CARE COSTS IN PATIENTS HOSPITALIZED WITH HEART FAILURE (2014) (0)
- Abstract 12: Heart Failure Medications Prescribed at Discharge for Patients With Left Ventricular Assist Devices (2016) (0)
- lyzed trends in the use of ventricular assist devices alone or after open-heart surgery for all (2008) (0)
- Abstract 1293: Antithrombotic Therapy at Hospital Discharge Performance Measure in Ischemic Stroke and Clinical Outcomes (2009) (0)
- TIME OF PRESENTATION AMONG PATIENTS HOSPITALIZED FOR ACUTE HEART FAILURE (CLINICAL CHARACTERISTICS, INITIAL THERAPIES AND OUTCOMES): INSIGHTS FROM ASCEND-HF (2017) (0)
- Abstract 17: Association Between Pre-stroke Depression and Patient Reported Outcomes After Acute Ischemic Stroke (2018) (0)
- Statistical Code for Clinical Research Papers. (2019) (0)
- 1224-P: Multidimensional Characterization of Prediabetes in the Project Baseline Health Study (2022) (0)
- Characterization of Heart Failure Patients With Preserved Systolic Function: A Comparison between ADHERE-US Registry and ADHERE-International Registry (2010) (0)
- 9 Outcomes in Destination Therapy VAD and Extended Criteria Cardiac Transplantation Stratified by HeartMate Risk Score (2012) (0)
- Abstract 452: A Unique Acylcarnitine Profile is Independently Associated with Diabetic Heart Failure and Associates with Adverse Clinical Outcomes: Insights from the FIGHT Trial (2019) (0)
- P1732Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy (2017) (0)
- Differential Response to Low Dose Dopamine or Nesiritide in Patients with Acute Heart Failure and Renal Dysfunction in Accordance to LV EF: Sub-Group Analysis of the ROSE AHF Trial (2014) (0)
- Response to Letter Regarding Article, "Temporal Trends and Variation in Early Scheduled Follow-up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure. (2016) (0)
- Concordance Between Patient-Reported Health Data and Electronic Health Data in the ADAPTABLE Trial. (2022) (0)
- Abstract W P269: High vs. Moderate-intensity Statin Therapy After Ischemic Stroke: Findings from PROSPER (2015) (0)
- 696: Comparison of Early and Late Calcineurin Inhibitor Initiation after Basiliximab Induction in Heart Transplantation (2009) (0)
- In Reply: B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: Insights from the ADHERE registry. (2013) (0)
- Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure with Reduced Ejection Fraction: The VICTORIA Biomarker Substudy. (2023) (0)
- Abstract 10990: Regulatory Implications of Different Definitions and Outcomes in Worsening Heart Failure (2015) (0)
- DECONGESTION, QUALITY OF LIFE, AND CLINICAL OUTCOMES AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE WITH REDUCED VERSUS PRESERVED EJECTION FRACTION (2022) (0)
- IVC Filters and Postoperative Outcomes in Patients Undergoing Bariatric Surgery: A Meta-analysis (2013) (0)
- OUTCOMES ASSOCIATED WITH SAME-DAY DISCHARGE AFTER ELECTIVE PLACEMENT OF A PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AMONG OLDER PATIENTS (2014) (0)
- Abstract 15103: Inefficient Ventilation is an Easily Derived Marker of Cardiovascular Reserve Capacity in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study (2013) (0)
- Early International Normalized Ratio (INR) Monitoring and Long-Term Clinical Outcomes in Warfarin Users with Heart Failure: Findings from ADHERE Linked with Medicare Claims (2012) (0)
- Abstract 203: Use of Endovascular Therapy and Trends in Clinical Outcomes within the Nationwide Get With The Guidelines-Stroke Registry (2015) (0)
- Abstract 24: Current Quality of Cardiovascular Prevention for Million Hearts™: An Analysis of 115,737 Outpatients from The Guideline Advantage™ (2013) (0)
- Abstract 7: Risk of Intracranial Hemorrhage Among Acute Ischemic Stroke Patients Receiving Prior Antiplatelet Therapy and Treated with Intravenous Tissue Plasminogen Activator (2014) (0)
- 508 Acute heart failure: Canadian perspectives from an RCT and a registry (2011) (0)
- Abstract 17325: Association of Risk Adjusted 30 Day Heart Failure Readmission Rates Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes: Findings From the American Heart Association Get With the Guidelines-Heart Failure Program (2016) (0)
- Geographic variation in heart failure with reduced ejection fraction: insights from the VICTORIA trial (2022) (0)
- Abstract 131: Impact of Concomitant Use of Antiplatelet and Anticoagulation Therapies on Outcomes in Patients With Intracerebral Hemorrhage (2018) (0)
- Outcomes of Medicare Beneficiaries With Ventricular Assist Devices—Reply (2009) (0)
- Abstract 15590: Intracranial Hemorrhage in Patients Receiving Non-Vitamin K Oral Anticoagulants (2017) (0)
- Diabetes is Associated with Worse In-Hospital and 30-Day Post-Discharge Morbidity in Patients with Heart Failure with Preserved Ejection Fraction: Findings from the Get With The Guidelines Heart Failure Registry (2018) (0)
- Abstract 8398: Trends in Clinical and Demographic Features of Patients with Acute Myocardial Infarction in the First Decade of the 21st Century. A Report from the American Heart Association Get-With-The-Guidelines Coronary Artery Disease Program (2011) (0)
- Leveraging “Big Data” for the Design and Execution of Clinical Trials (2021) (0)
- Abstract T MP98: Guideline-directed LDL Management Prior to Onset of Acute Ischemic Stroke in Patients with and Without Pre-existing Cardiovascular Disease: Findings from GWTG-stroke (2014) (0)
- Abstract W P144: Depressive Symptoms and Risk of Stroke in African Americans: Findings from the Jackson Heart Study (2015) (0)
- 1108-120 A gap in care: Heart failure patients undergoing major noncardiac surgery (2004) (0)
- PERMANENT PACEMAKER USE AND OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (2014) (0)
- Abstract 13829: Index Event, Clinical Outcomes and Response to Vericiguat in the Victoria Trial (2020) (0)
- DECONGESTION STRATEGIES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ACTIVATION IN ACUTE HEART FAILURE (2014) (0)
- CHARACTERISTICS AND OUTCOMES OF TRIAL-ELIGIBLE VS INELIGIBLE PATIENTS WITH HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION (2023) (0)
- GENDER DIFFERENCES IN BASELINE CHARACTERISTICS, QUALITY OF CARE MEASURES, AND OUTCOMES AMONG PATIENTS HOSPITALIZED WITH ACUTE DECOMPENSATED HEART FAILURE IN ASIA-PACIFIC AND LATIN AMERICA REGIONS: ANALYSIS OF THE ACUTE DECOMPENSATED HEART FAILURE INTERNATIONAL REGISTRY (ADHERE-INTERNATIONAL) (2012) (0)
- 650 Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial: Findings From ASCEND-HF (2012) (0)
- PROTEOMIC MARKERS OF CARDIAC FIBROSIS AND ENDOTHELIAL FUNCTION ASSOCIATED WITH HEART FAILURE IN PATIENTS WITH DIABETES: AN EXSCEL BIOMARKER SUB-STUDY (2023) (0)
- Cangrelor Use in the Treatment of Left Ventricular Assist Device Thrombosis : A Case Report (0)
- CARDIAC RESYNCHRONIZATION THERAPY IN THE ELDERLY (2013) (0)
- Abstract 16125: Prognostic Value of C-Reactive Protein as Inflammatory Marker for Venous Thromboembolism in Acutely Ill Hospitalized Patients: Analysis From the APEX Trial (2018) (0)
- Abstract 10: Pre-stroke Antithrombotic Therapy and Stroke Severity in Acute Ischemic Stroke Patients with Atrial Fibrillation (2016) (0)
- Use Of Sacubitril-valsartan And Associated Outcomes By Race And Ethnicity In Patients With Heart Failure With Reduced Ejection Fraction: Data From Champ-HF (2022) (0)
- Influence on the American Heart Association's Get With the Guidelines (GWTG) heart failure program on the quality of care for patients hospitalized with heart failure (2006) (0)
- COMPARISON OF HOSPITAL PERFORMANCE OF ACUTE MYOCARDIAL INFARCTION AND HEART FAILURE QUALITY MEASURES: FINDINGS FROM THE GET WITH THE GUIDELINES REGISTRY (2010) (0)
- Abstract 10413: Clinical Outcomes with Metformin and Sulfonylurea Initiation Among Patients with Heart Failure and Diabetes: From Get with the Guidelines-Heart Failure (2021) (0)
- Biologic markers in acute heart failure (2005) (0)
- Abstract W P272: Healthcare Resource Availability, Acute Ischemic Stroke Outcomes and Quality of Care (2015) (0)
- CLASSIFICATION AND IMPLICATIONS OF HEART FAILURE EVENTS FROM THE VICTORIA TRIAL (2022) (0)
- Abstract WP297: Increasing Interfacility Transfers Among Northeastern Hospitals in the Care of Stroke Patients (2018) (0)
- Abstract 18746: Variation in Intravenous Inotrope Use for Patients Hospitalized with Heart Failure: Data from Get withthe Guidelines (2012) (0)
- IMPACT OF DIASTOLIC DYSFUNCTION ON POST-OPERATIVE OUTCOMES AFTER CARDIAC SURGERY: A META-ANALYSIS (2015) (0)
- Abstract 14697: Ventricular Conduction and Long-term Outcomes in African Americans: Insights from the Jackson Heart Study (2014) (0)
- Disease-Based Registries in Improving Quality and Outcomes Synthesizing Lessons Learned From Get With The Guidelines: The Value of (2013) (0)
- METABOLOMIC PROFILING IN HEART FAILURE IDENTIFIES BIOMARKERS OF MITOCHONDRIAL FUNCTION IN PRESERVED VERSUS REDUCED EJECTION FRACTION (2015) (0)
- Prognostic Value Of Composite Biomarkers In ASCEND-HF Biomarker Registry (2023) (0)
- Abstract 227: Prescribing Warfarin at Discharge for Heart Failure Patients without Atrial Fibrillation Findings from the Get With The Guidelines-Heart Failure Registry (2013) (0)
- INTRAVASCULAR BLOOD VOLUME ANALYSIS AND HEMODYNAMIC MEASURES OF VASCULAR COMPLIANCE IN PATIENTS HOSPITALIZED FOR HEART FAILURE (2022) (0)
- Transient and Persistent Worsening Renal Function during Acute Heart Failure Hospitalization: Insights from the ADHERE Registry Linked to Medicare Claims (2014) (0)
- Abstract 16757: Early Ambulation Among Hospitalized Heart Failure Patients is Associated With Decreased Length of Stay and Higher Rates of Discharge to Home (2016) (0)
- Abstract 173: Patterns and Predictors of Emergency Medical Services Pre-Notification of Potential Stroke Cases in the United States: Findings from GWTG-Stroke (2012) (0)
- Abstract 5856: Long-term Outcomes and Costs of Ventricular Assist Devices among United States Medicare Beneficiaries (2008) (0)
- CIRCULATING SURFACTANT PROTEINS, DYSPNEA, AND MARKERS OF CONGESTION IN ACUTE DECOMPENSATED HEART FAILURE: REPORT FROM THE DIURETIC OPTIMIZATION STRATEGIES EVALUATION (DOSE) STUDY (2014) (0)
- PERIPHERAL ARTERIAL DISEASE TESTING PRIOR TO AMPUTATION IN MEDICARE PATIENTS (2013) (0)
- PCV94 PREDICTING HIGH COSTS IN MEDICARE BENEFICIARIES WITH HEART FAILURE (2008) (0)
- Abstract TMP70: Hospital Factors Associated With Interhospital Stroke Transfer Destination in the Northeast United States (2019) (0)
- Abstract 16863: Racial Differences in Atrial Fibrillation Prevalence and Anticoagulation Use (2012) (0)
- CHARACTERIZING THE DIGITAL DIVIDE & ACCESS TO MOBILE HEALTH INTERVENTIONS IN HEART FAILURE: INSIGHTS FROM THE CONNECT-HF MHEALTH SUBSTUDY (2023) (0)
- Abstract 9: Consistency of Laboratory Monitoring during Initiation of Mineralocorticoid Receptor Antagonists in Heart Failure (2015) (0)
- Abstract 5595: Secondary Prevention Performance Measures in Acute Coronary Syndrome Patients with Prior Monovascular or Polyvascular Atherosclerosis in the Get with the Guidelines Database (2008) (0)
- EARLY IMPACT OF GUIDELINE PUBLICATION ON ANGIOTENSIN-RECEPTOR NEPRILYSIN INHIBITOR USE AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE (2018) (0)
- Measuring heart failure quality: does perfection matter? (2015) (0)
- Abstract 15192: Implementation of the Hospital Readmissions Reduction Program, Readmissions, and Mortality in Heart Failure (2017) (0)
- Abstract 15978: Combined Use of Warfarin and Oral P2Y12 Inhibitors in Patients With Atrial Fibrillation and Acute Coronary Syndrome (2013) (0)
- Abstract T P313: Sex-age Interactions and Differences in Outcomes After Intracerebral Hemorrhage (2015) (0)
- POPULATION-SPECIFIC GENETIC VARIATIONS INCREASE HAZARD OF MORTALITY OR REHOSPITALIZATION IN HEART FAILURE PATIENTS (2018) (0)
- EJECTION FRACTION, BIOMARKERS, AND OUTCOMES IN HEART FAILURE WITH REDUCED EJECTION FRACTION AND THE IMPACT OF VERICIGUAT ON OUTCOMES IN THE VICTORIA TRIAL (2022) (0)
- Abstract 35: Safety and Outcomes of Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke Patients With Recent Stroke: Findings From Get With the Guidelines-Stroke (2019) (0)
- Third and fourth heart sounds had low sensitivity but moderate to high specificity for predicting left ventricular dysfunction. (2005) (0)
- Trends in the Use of Guideline-based Therapies Among Dialysis Patients Hospitalized with Heart Failure: Findings from Get With The Guidelines-Heart Failure (2015) (0)
- Abstract 13770: Geographic Variation in Clinical Course Among Patients Hospitalized for Acute Heart Failure: Insights From ASCEND-HF (2011) (0)
- Abstract 17304: Sudden Cardiac Death After Acute Heart Failure Hospitalization: Insights From ASCEND-HF (2015) (0)
- Review: implantable cardioverter defibrillators reduce all-cause mortality in nonischemic cardiomyopathy. (2005) (0)
- Abstract 149: Care for Heart Failure Patients at the End of Life: Hospital Readmission and Mortality Amongst Heart Failure Patients Discharged to Hospice (2018) (0)
- Abstract TMP70: Assessment of Home Time Following Acute Ischemic Stroke in Medicare Beneficiaries (2016) (0)
- A Hospital and Postdischarge Quality Improvement Intervention and Outcomes and Care for Patients With Heart Failure With Reduced Ejection Fraction-Reply. (2021) (0)
- Rationale and Design for the UNC Duke Acute Decompensated Heart Failure with Hypertension Study (UNDU ADHF-HTN) (2007) (0)
- Abstract 3173: Have Door-to-Balloon Times Improved After Initiation of the D2B Alliance? An Analysis of the Get-with-the-Guidelines Registry (2008) (0)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (0)
- SPLANCHNIC NERVE MODULATION EFFECTS ON SURROGATES MEASURES OF VENOUS COMPLIANCE (2022) (0)
- Performance On Guideline Directed Medical Therapy Remains Low In A Cluster-randomized Trial: Results From CONNECT-HF (2022) (0)
- 2035 FAMILY HISTORY OF PROSTATE CANCER DOES NOT INCREASE THE RISK OF DETECTION OF PROSTATE CANCER NOR HIGH GRADE DISEASE IN MEN UNDERGOING INITIAL PROSTATE BIOPSY (2011) (0)
- HYPOTENSION IN ACUTE DECOMPENSATED HEART FAILURE: FINDINGS FROM ASCEND-HF (2013) (0)
- Abstract 13897: Decreased Diuretic Efficiency Rather Than Total Diuretic Dose is Associated With Reduced Survival Following Heart Failure Hospitalization (2014) (0)
- Improvements in Health Status Associated with Medication Adjustments in Outpatients with HFrEF: Insights from the CHAMP-HF Registry (2018) (0)
- Abstract 67: Endovascular Thrombectomy In Patients With Acute Ischemic Stroke And Recent Use Of Oral Vitamin K-Antagonists: The Get With The Guidelines-Stroke Program (2023) (0)
- Abstract 16818: Circulating Cardiac Troponin I as Detected By a High-Sensitivity Assay among Patients Hospitalized with Acute Decompensated Heart Failure (2011) (0)
- Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials). (2022) (0)
- Abstract 14185: Heart Failure Occurring at any Time During Hospitalization is Associated with Higher Mortality in Non-ST Elevation-Acute Coronary Syndromes (2011) (0)
- Abstract 257: Discharge Heart Rate and Beta-blocker Dose in Patients Hospitalized with Acute Heart Failure (2015) (0)
- Abstract 17901: A Comparison of Temporal Trends in In-hospital Adherence to Secondary Prevention Measures Among Patients Undergoing Coronary Artery Bypass Graft Surgery, Percutaneous Coronary Intervention or No Intervention: Insights From the GWTG-CAD (2012) (0)
- Trends and Outcomes of Patients with Adult Congenital Heart Disease With Pulmonary Hypertension Listed for Orthotopic Heart Transplantation in the United Network for Organ Sharing Database (2015) (0)
- Abstract 16697: Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From the American Heart Association’s Get With the Guidelines-Heart Failure Registry (2016) (0)
- Abstract 807: Incremental Value of Clinical Data Beyond Claims to Predict 30-Day Outcomes Following Heart Failure Admission: Results From the AHA's Get With the Guidelines-Heart Failure Registry (2009) (0)
- Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction (2022) (0)
- CHARACTERISTICS, TREATMENTS, AND OUTCOMES OF HOSPITALIZED HEART FAILURE PATIENTS STRATIFIED BY ETIOLOGIES OF NON-ISCHEMIC CARDIOMYOPATHY (2014) (0)
- Patient and Practice Characteristics Associated with Sacubitril/Valsartan Use in the United States (2018) (0)
- Abstract 19522: Trends and Outcomes in Mechanical Circulatory Support Among Medicare Beneficiaries (2012) (0)
- Evaluation of tumor- and stromal immune marker heterogeneity in non-small cell lung cancer (2016) (0)
- Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial. (2022) (0)
- Abstract 17979: Global Metabolomic Profiling in Heart Failure With Preserved Ejection Fraction Identifies Markers of Myocardial Dysfunction (2016) (0)
- Insufficient Reduction in Heart Rate during Hospitalization Despite Beta-Blocker Treatment in Acute Decompensated Heart Failure (2016) (0)
- Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study (2023) (0)
- Abstract 9: Clinical Effectiveness of Statin Therapy after Ischemic Stroke: Primary Results from the PROSPER Study (2015) (0)
- Design and Architecture of a Distributed Network Pragmatic Clinical Trial: The PCORnet ADAPTABLE Study (2016) (0)
- A gender and racial gap in internal cardioverter defibrillator use among hospitalized heart failure patients: Data from the American Heart Association's Get With the Guidelines Heart Failure (GWTG-HF) Program (2007) (0)
- POST-DISCHARGE MORTALITY AND READMISSION IN HEART FAILURE PATIENTS WITH PRESERVED, BORDERLINE, AND REDUCED LEFT VENTRICULAR EJECTION FRACTION (2014) (0)
- Abstract 5623: Early Antithrombotic Therapy Performance Measure in Ischemic Stroke and Clinical Outcomes (2009) (0)
- HEMOCONCENTRATION DURING MANAGEMENT OF PATIENTS WITH ACUTE HEART FAILURE AND CARDIORENAL SYNDROME: INSIGHTS FROM CARRESS-HF (2017) (0)
- Cardiohepatic Interactions in Heart Failure (2013) (0)
- Aldosterone Antagonists in Patients With Heart Failure. Authors' reply (2010) (0)
- INFLUENCE OF CLINICAL TRIAL SITE ENROLLMENT ON PATIENT CHARACTERISTICS, PROTOCOL COMPLETION, AND ENDPOINTS: INSIGHTS FROM THE ASCEND-HF TRIAL (2016) (0)
- Abstract 300: Race/Ethnicity Is Not Associated with Longer Door to Balloon Time or Increased Mortality in Patients Undergoing Primary PCI for STEMI: Findings from AHA-GWTG (2012) (0)
- Abstract 295: Potential Effectiveness for Anticoagulation Among Elderly Heart Failure Patients without Atrial Fibrillation? An Analysis of the ADHERE Registry Linked to Medicare Claims (2012) (0)
- 301 - The Burden of Non-Cardiac Comorbidities in Acute Heart Failure: Insights From ASCEND-HF (2017) (0)
- Circ Heart Fail July 2014 Age , Sex , Body Size , Hemoglobin , and Chronotropic Reserve as Predictors of Peak VO (0)
- HOSPITAL VARIATION IN PERIOPERATIVE INSULIN USE AND GLUCOSE CONTROL IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFT SURGERY (2013) (0)
- Statistical Code for Clinical Research Papers. (2019) (0)
- THE RELATIONSHIP BETWEEN BODY WEIGHT CHANGE DURING HOSPITALIZATION FOR ACUTE HEART FAILURE AND PATIENT CHARACTERISTICS, MARKERS OF CONGESTION, AND OUTCOMES: FINDINGS FROM ASCEND-HF (2016) (0)
- HEART FAILURE WITH REDUCED EJECTION FRACTION CARE PATTERNS IN THE OUTPATIENT PRACTICE SETTING: INITIAL FINDINGS FROM CHAMP-HF (2017) (0)
- Abstract 122: Comparative Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Older Adults With Diabetes Mellitus: Insights From the Get With the Guidelines - Heart Failure Registry (2018) (0)
- Abstract 114: Equitable Improvements in Sex and Race/Ethnic Specific Door-to-Needle Times in Acute Ischemic Stroke: Findings From Target: Stroke Phase I (2016) (0)
- Unsupervised Machine Learning To Define Acute Hfpef Phenotypes: Findings From Ascend-hf (2022) (0)
- Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Trial. (2023) (0)
- Abstract 1287: The Impact of Different Ranking Methods for Hospital's Heart Failure Quality of Care: Results From the AHA' s Get With the Guidelines-Heart Failure Registry (2009) (0)
- Abstract 14658: Comparative Effectiveness of Torsemide versus Furosemide in Acute Heart Failure Patients: Insights from ASCEND-HF (2014) (0)
- Estimated Long-Term Bene fi t of Dapagli fl ozin in Patients With Heart Failure (0)
- IMPACT OF TRICUSPID DISEASE IN PATIENTS WITH CONGESTIVE HEART FAILURE AND MITRAL VALVE DISEASE: A NATIONWIDE COHORT STUDY (2019) (0)
- Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions (2022) (0)
- Patients With Type 2 Diabetes Are More Resistant To Diuresis And Have Worse Acute Heart Failure Outcomes: Findings From ASCEND-HF (2023) (0)
- Statistical Code for Clinical Research Papers. (2019) (0)
- EFFECTS OF ALBIGLUTIDE ON TYPES AND NUMBERS OF MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE IN THE HARMONY OUTCOMES TRIAL (2023) (0)
- Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study. (2023) (0)
- Abstract 11459: Mitochondrial Metabolites Predict Cardiovascular Outcomes and Heart Failure in Individuals with Type 2 Diabetes Mellitus: An Exscel Biomarker Substudy (2021) (0)
- Disseminating trial results: We can have both faster and better (2020) (0)
- Four or More Reviews (2016) (0)
- Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA. (2023) (0)
- THE IMPACT OF THE CURRENT VERSUS PRIOR CARDIAC RESYNCHRONIZATION GUIDELINES ON THE PROPORTION OF HOSPITALIZED HEART FAILURE PATIENTS ELIGIBLE FOR THERAPY (2017) (0)
- Elevated Total Bilirubin on Admission is a Marker of Worse 30- and 180-Day Outcomes for Patients With Acute HF: Insights From ASCEND-HF (2015) (0)
- Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. (2023) (0)
- Clinical Investigations Thrombolytic Therapy for Thrombosis of Continuous Flow Ventricular Assist Devices (2014) (0)
- Abstract 13793: National Survey of Care Processes to Reduce Readmission in Patients Hospitalized for Heart Failure: Factors Associated with Lower Readmission Rates (2011) (0)
- Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/valsartan versus Valsartan in HFmrEF and HFpEF with a Worsening Heart Failure Event. (2023) (0)
- Abstract TP314: Current Use of Strategies to Improve Door-to-Needle Times With Tissue Plasminogen Activator in Acute Ischemic Stroke: Findings From the Target: Stroke Phase II Survey (2016) (0)
- Assessing Heuristic Bias During Care for Patients Hospitalized for Heart Failure: Get With The Guidelines-Heart Failure (2022) (0)
- P6072Characterization of major and clinically relevant non-major bleeding in the APEX trial (2018) (0)
- Splanchnic nerve block with botulinum toxin for therapy of chronic heart failure – mechanism of action (SPONGE‐HF) (2023) (0)
- Congestive Heart Failure Relationships between emerging measures of heart failure processes of care and clinical outcomes (2010) (0)
- Abstract 8839: Acute Heart Failure: Canadian Perspectives from an RCT and a Registry (2011) (0)
- EFFECTIVENESS AND SAFETY OF ASPIRIN IN SECONDARY PREVENTION OF CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A SUBGROUP ANALYSIS OF ADAPTABLE (2022) (0)
- A multicenter program for electronic health record screening for patients with heart failure with preserved ejection fraction: Lessons from the DELIVER-EHR initiative. (2022) (0)
- Abstract 9811: Medical Resource Use, Costs and Quality of Life are Similar Between Patients with Acute Decompensated Heart Failure Treated with Nesiritide Versus Placebo (2011) (0)
- Aldosterone Antagonists in Patients With Heart Failure—Reply (2010) (0)
- THE ASSOCIATION BETWEEN ANTICOAGULATION AND LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION: FINDINGS FROM THE ADHERE REGISTRY (2012) (0)
- Abstract 17232: Eliminate Thromboembolism: Improving Anticoagulation in Non-Valvular Atrial Fibrillation Patients' (ELITE) Registry - Insights From the Baseline Results (2017) (0)
- Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial (2023) (0)
- Abstract 17298: Comparative Effectiveness of Sulfonylurea versus Metformin in Patients With Heart Failure and Diabetes Mellitus (2017) (0)
- Grodin, J. L. et al. (2018) Circulating cardiac troponin I levels measured by a novel highly sensitive assay in acute decompensated heart failure: insights from the ASCEND-HF (2018) (0)
- TEMPORAL TRENDS IN EARLY FOLLOW-UP AFTER HOSPITALIZATION FOR HEART FAILURE: DATA FROM GET WITH THE GUIDELINES-HEART FAILURE (2014) (0)
- SEX DIFFERENCES IN EFFECTIVENESS AND SAFETY OF ASPIRIN IN SECONDARY PREVENTION OF CARDIOVASCULAR OUTCOMES IN PATIENTS: A SUBGROUP ANALYSIS FROM THE ADAPTABLE STUDY (2022) (0)
- Temporal Trends of Digoxin Use in Patients Hospitalized with Heart Failure: Analysis From the American Heart Association Get With The Guidelines - Heart Failure Registry (2015) (0)
- Abstract 26: Clinical models of 30-day outcomes among Medicare beneficiaries hospitalized with heart failure and preserved or reduced ejection fraction: derivation and validation of models from the Get With The Guidelines-Heart Failure Registry and Medicare Linked Database (2012) (0)
- REFERRAL TO HOSPICE AND PREDICTED MORTALITY RISK AMONG PATIENTS HOSPITALIZED WITH HEART FAILURE: FINDINGS FROM GWTG-HF (2011) (0)
- Follow-Up Lowers Heart Failure Readmissions (2010) (0)
- INTERNATIONAL VARIATION IN CARE AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE: AN ANALYSIS OF THE ACUTE DECOMPENSATED HEART FAILURE NATIONAL REGISTRY UNITED STATES AND ACUTE DECOMPENSATED HEART FAILURE REGISTRY INTERNATIONAL (2011) (0)
- Abstract 25: Safety And Outcomes Of Endovascular Thrombectomy In Acute Ischemic Stroke Patients With Recent Use Of Non-vitamin K Antagonist Oral Anticoagulants (2023) (0)
- Abstract 13158: Hospitalization for De Novo versus Worsening Chronic Heart Failure: Insights From the ASCEND-HF Trial (2016) (0)
- Abstract 3029: Improved Clinical Outcomes in Medicare Beneficiaries with Acute Ischemic Stroke During Initial Implementation of the Get With The Guidelines-Stroke (GWTG-S) Program 2003-2008 (2012) (0)
- Abstract 3798: Impact of Worsening Renal Function During Hospitalization for Heart Failure on 30 Day Outcomes Among Medicare Beneficiaries in OPTIMIZE-HF (2009) (0)
- Does Hospital Length of Stay for Heart Failure Influence Compliance with Performance Measures? (2007) (0)
- CHARACTERIZING RENAL FUNCTION IN STANDARD AND EXTENDED CRITERIA CARDIAC TRANSPLANT PATIENTS: A 10-YEAR EXPERIENCE (2012) (0)
- Abstract 10420: Utilization of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure: Has it Changed and is it Associated With Patient Outcomes? (2015) (0)
- Heart Failure Hospitalization : Scope of the Problem Significance of HF on Hospitalization (0)
- Nesiritide Administration in Patients Hospitalized for Acute Decompensated Heart Failure: Does Timing Matter? (2013) (0)
- 42 The Importance of Low-Titer Anti-HLA Antibodies in Cardiac Transplantation (2011) (0)
- Regional Differences during Acute Heart Failure Hospitalizations of Patients with Heart Failure with Preserved Ejection Fraction: Insights From ASCEND-HF (2016) (0)
- If You Build It, They Will Come: The National Patient-Centered Clinical Research Network (PCORnet): From Conception to Execution (2019) (0)
- Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized with Heart Failure (2019) (0)
- High Sensitivity Troponin I in Acute Decompensated Heart Failure (2011) (0)
- Abstract 1: The Impact of State Medicaid Expansions on Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure (2018) (0)
- 349-OR: Major Cardiovascular Outcomes among At-Risk High-Deductible Health Plan Members (2019) (0)
- Abstract P269: Linkage of Patients in a National Heart Failure Clinical Registry to Medicare Claims Data: An Analysis of Generalizability and Longitudinal Outcomes from ADHERE (2011) (0)
- Potential Mortality ReductionWith Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure (2016) (0)
- Baseline Cystatin C is Associated with Short-Term Adverse Events in Acute Heart Failure but Does Not Predict Treatment Effects with Nesiritide Therapy (2011) (0)
- Abstract 12817: Comparison of New York Heart Association Classification and Patient-reported Outcomes Among Heart Failure Patients in U.S. Clinical Practice: CHAMP-HF (2020) (0)
- Abstract 11961: Clinical, Physiologic, and Functional Characterization of Patients With Diabetes and Heart Failure With Preserved Ejection Fraction: Data From the Heart Failure Network RELAX Study (2013) (0)
- Abstract 90: Contemporary Use of Renin-Angiotensin System Blockers in Acute Coronary Syndromes: Findings from Get With The Guidelines-Coronary Artery Disease Program (2012) (0)
- Response to Letter Regarding Article, "Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women". (2016) (0)
- Abstract P83: Predictors of Length of Stay for HF Patients: Results from Get With the Guidelines (2011) (0)
- 54: Bleeding and Thromboembloic Complications with Pulsatile Versus Non-Pulsatile LVADs (2009) (0)
- Abstract 13554: Impaired Functional Capacity in Patients With Obstructive Sleep Apnea Predicts Mortality (2011) (0)
- PRIOR HEART FAILURE HOSPITALIZATION AMONG PATIENTS HOSPITALIZED FOR WORSENING CHRONIC HEART FAILURE: FROM THE ASCEND-HF TRIAL (2018) (0)
- Worsening Heart Failure During Hospitalization for Acute Heart Failure: Insights from ASCEND-HF (2015) (0)
- Protein biomarkers of cardiac remodeling and inflammation associated with HFpEF and incident events (2022) (0)
- 819 Does a Low Ejection Fraction Predict Mortality? Insights From the ASCEND-HF Trial (2012) (0)
- INTERLEUKIN-6 IS ASSOCIATED WITH, BUT DOES NOT INDEPENDENTLY PREDICT, MORTALITY IN ACUTE HEART FAILURE: AN ASCEND-HF SUBSTUDY (2015) (0)
- Poor Medication Adherence Is Associated With Worse Health Status In Heart Failure With Reduced Ejection Fraction (2022) (0)
- Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?-Reply. (2022) (0)
- Abstract 18877: The Scope of Sacubitril/Valsartan Eligibility Post-Heart Failure Hospitalization: Findings From the Get With the Guidelines-Heart Failure Registry (2016) (0)
- THE EFFECT OF DAPAGLIFLOZIN ON INSULIN INITIATION OR INTENSIFICATION IN PATIENTS IN HEART FAILURE AND DIABETES: A POOLED ANALYSIS OF DAPA-HF AND DELIVER (2023) (0)
- Abstract 14069: Cardiac Transplantation Unmasks Profound Muscle Weakness and Leads to Diagnosis of a Rare Cardiomyopathy (2013) (0)
- IMPACT OF HEART FAILURE HOSPITALIZATION ON GUIDELINE-DIRECTED MEDICAL THERAPY PRESCRIBING PATTERNS AMONG PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: AN ANALYSIS FROM CHAMP-HF (2020) (0)
- PREVALENCE, PREDICTORS AND EFFECTS OF NESIRITIDE ON CHANGES IN RENAL FUNCTION DURING HOSPITALIZATION FOR ACUTE DECOMPENSATED HEART FAILURE (2013) (0)
- Carvedilol reduced mortality and hospital admission in severe chronic heart failure, regardless of pretreatment systolic BP (2005) (0)
- The Clinical Implications of Cardiac Troponin I Measured by an “Ultrasensitive” Assay in Acute Decompensated Heart Failure: Insights from ASCEND-HF (2015) (0)
- Clinical Investigation The Obesity and Heart Failure Epidemics Among African Americans: Insights From the Jackson Heart Study (2016) (0)
- USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF (2019) (0)
- ASSOCIATION BETWEEN ASSIGNMENT TO AN ACCOUNTABLE CARE ORGANIZATION AND QUALITY OF CARE AND OUTCOMES AMONG MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE (2019) (0)
- Abstract TMP14: Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients With Recent Myocardial Infarction (2019) (0)
- SOLUBLE NEPRILYSIN IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (2019) (0)
- Abstract 10426: Worse Clinical Outcomes in Patients with Acute Coronary Syndrome and Prior or New Onset Heart Failure: Insights from 47,474 Patients in a Pooled Analysis of Randomized Clinical Trials (2021) (0)
- Abstract 13608: Center Variation in Home Time Following Acute Ischemic Stroke (2015) (0)
- Abstract 8440: Guideline Recommended Evaluation in Patients with a First Episode of Atrial Fibrillation (2011) (0)
- Are heart failure patients undergoing major noncardiac surgery overlooked (2003) (0)
- Addressing the 100% of heart failure: a call for complete care of all ages. (2012) (0)
- Abstract 16058: Country Income Level, Protocol Completion, and Trial Endpoints Among Patients With Acute Heart Failure: Insights From the ASCEND-HF Trial (2017) (0)
- Abstract P206: Differences in the Characteristics of Medicare Beneficiaries with Heart Failure According to Enrollment in the Medicare Part D Prescription Drug Benefit (2011) (0)
- CORONARY ARTERY DISEASE AND CARDIOVASCULAR OUTCOMES IN HEART FAILURE: INSIGHTS FROM THE VERICIGUAT GLOBAL STUDY IN SUBJECTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (VICTORIA) TRIAL (2021) (0)
- 1114 ROBOTIC PARTIAL NEPHRECTOMY VERSUS LAPAROSCOPIC CRYOABLATION FOR THE SMALL RENAL MASS (2012) (0)
- Abstract WMP19: Are “Drip and Ship” Patients Different than Other rt-PA Treated Patients? Clinical Characteristics and Patient Outcomes. (2013) (0)
- Abstract 15673: 30-Day Outcomes Associated With Atrial Fibrillation in Patients With Heart Failure and Reduced and Preserved Ejection Fraction (2013) (0)
- Abstract 377: Characteristics, Care, and Outcomes of Asian American Heart Failure Patients: Findings from the American Heart Association Get With The Guidelines-Heart Failure Program (2014) (0)
- Abstract 9232: Admission Heart Rate and In-Hospital Outcomes in Patients Hospitalized for Heart Failure (2012) (0)
- SACUBITRIL-VALSARTAN FOLLOWING HOSPITAL DISCHARGE FOR HEART FAILURE (2020) (0)
- Changes in serum calcitonin concentrations and incidence of adjudicated medullary thyroid carcinoma in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) (2018) (0)
- CARE AND OUTCOMES OF HISPANICS ADMITTED WITH HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION: FINDINGS FROM GET WITH THE GUIDELINES-HEART FAILURE (2011) (0)
- PHARMACOGENOMIC ANALYSES IN ASCEND-HF INDICATE INFLUENCE OF NPR3ON NESIRITIDE BLOOD PRESSURE EFFECT (2021) (0)
- Review: Cardiac resynchronization reduces mortality and hospitalizations in patients with either more or less symptomatic HF (2011) (0)
- Efficacy and safety of vericiguat in patients with HFrEF treated with sacubitril/valsartan: results from the VICTORIA trial (2021) (0)
- Abstract P92: Racial Differences in End of Life Care in Medicare Beneficiaries With Heart Failure (2011) (0)
- Abstract 102: Adherence to ECASS III 3-4.5 Hour Exclusion Criteria and Association with Outcome in Clinical Practice: Data from Get With The Guidelines (GWTG)-Stroke (2013) (0)
- Authors' Reply (2014) (0)
- Vericiguat and health status outcomes in heart failure with reduced ejection fraction: insights from the VICTORIA trial (2021) (0)
- Abstract 16571: The Potential Impact of Expanding Cardiac Rehabilitation Coverage in Heart Failure: Insights From Get With the Guidelines Heart Failure (2015) (0)
- What is the best measure for rewarding quality of care: Defect-free vs. composite scoring? An analysis from the American Heart Association's Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) Program (2007) (0)
- Validation of Cardiovascular End Points Ascertainment Leveraging Multisource Electronic Health Records Harmonized Into a Common Data Model in the ADAPTABLE Randomized Clinical Trial. (2021) (0)
- Comparing Different Treatments for People Who Have Had a Stroke—The PROSPER Study (2020) (0)
- Abstract 39: Systematic Review of Radiographic and Symptomatic Brain Infarcts in Carotid Artery Interventions (2016) (0)
- Abstract 18524: Left Atrial Function is Associated With Cardiopulmonary Performance in Heart Failure With Preserved Ejection Fraction: A Relax Substudy (2013) (0)
- Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL (2018) (0)
- Reply: Vaccination in Patients With Heart Failure: An Established Recommendation in Patients With Chronic Heart Disease. (2019) (0)
- The Call for Precision Health Trials in Older Adults: One Size Does Not Fit All. (2018) (0)
- Abstract 13302: Worsening Heart Failure During Acute Heart Failure Hospitalization: Insights from ASCEND-HF (2014) (0)
- Abstract 10: Intracranial Hemorrhage Risks among Warfarin Treated Acute Ischemic Stroke Patients Receiving Thrombolytic Therapy (2012) (0)
- Abstract 16347: Hypoalbuminemia and Its Association With Venous Thromboembolism in Acutely Ill Hospitalized Patients: Findings From the APEX Trial (2018) (0)
- Abstract 68: Risk Score for Intracranial Hemorrhage in Patients with Acute Ischemic Stroke Treated With Intravenous t-PA. (2012) (0)
- 1012-104 Safety of beta-blockers in patients with heart failure and renal insufficiency: Data from IMPACT-HF (2004) (0)
- Abstract 4735: Is Improved Adherence to Guideline Based Care Among Patients Hospitalized With Acute Myocardial Infarction Restricted to Lower Risk? (2009) (0)
- Abstract 15556: Effects of Left Ventricular Assist Device Support on microRNA Levels (2014) (0)
- Abstract TP305: International Comparison of Patient Characteristics and Performance Measures in Acute Ischemic Stroke: Analysis of the American Heart Association Get With the Guidelines-Stroke Registry and China National Stroke Registry (2016) (0)
- Preoperative Evaluation for Major Noncardiac Surgery (2016) (0)
- Abstract 19469: Outcomes in Extended-Criteria Caradiac Transplantation: A 10-Year Experience (2012) (0)
- LIMITED TESTING FOR CORONARY ARTERY DISEASE IN PATIENTS WITH NEW-ONSET HEART FAILURE: FINDINGS FROM GET WITH THE GUIDELINES - HEART FAILURE (2020) (0)
- ARE THERE DIFFERENCES IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR COUNSELING RATES AMONG ELIGIBLE PATIENTS HOSPITALIZED FOR HEART FAILURE? NATIONAL RESULTS FROM THE AMERICAN HEART ASSOCIATION’S GET WITH THE GUIDELINES- HEART FAILURE PROGRAM (2015) (0)
- Do BNP Levels and Prognostic Value Vary by Race/Ethnicity in Patients Hospitalized With Heart Failure? (2012) (0)
- 441 SURGICAL TREATMENT OF BILATERAL SYNCHRONOUS KIDNEY TUMORS: LONG-TERM FUNCTIONAL AND ONCOLOGICAL OUTCOMES (2010) (0)
- Depressive symptoms in heart transplant recipients in an alternate list program (2005) (0)
- Does Atrial Fibrillation Affect Outcomes in Patients Admitted With Acute Heart Failure? Insights From the Ascend-Hf Trial (2013) (0)
- Abstract MP28: Heart Rate At Hospital Discharge Is Associated With Adverse Long Term Outcomes In Patients With Heart Failure (2014) (0)
- Statistical Code for Clinical Research Papers. (2019) (0)
- HAS PUBLIC REPORTING OF READMISSIONS IMPROVED CARE FOR PATIENTS WITH HEART FAILURE (2015) (0)
- Abstract 12291: Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients With Gastrointestinal Malignancy or Recent Bleeding (2018) (0)
- Abstract 4206: Invasive Treatments for Obese Patients with CAD: An Explanation for the "Obesity Paradox"? Analysis of 130,139 Hospitalizations in Get With The Guidelines (2006) (0)
- Generalizability of RELAX-AHF Clinical Trial Patients to a Large US Registry (2013) (0)
- TCT-645 Cardiovascular Events and Hospital Resource Utilization Pre and Post Transcatheter Mitral Valve Repair in High Surgical Risk Patients. (2016) (0)
- Abstract W MP106: Clinical Effectiveness of Anticoagulation with Warfarin among Ischemic Stroke Patients with Atrial Fibrillation: Findings from the Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study (2015) (0)
- Geographic Variation in Clinical Course Among Patients Hospitalized for Acute Heart Failure (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Adrian F. Hernandez?
Adrian F. Hernandez is affiliated with the following schools:
- University of Minnesota
- University of Arizona
- Stanford University
- Michigan State University
- University of Colorado
- Massachusetts General Hospital
- Duke University
- University of Texas Southwestern Medical Center
- University of Pennsylvania
- University of Vermont
- University of Calgary
- University of California, Berkeley
